Nicotine addiction and psychiatric disorders
Open accessAbstract
Even though smoking rates have long been on the decline, nicotine addiction still affects 20% of the US population today. Moreover, nicotine dependence shows high comorbidity with many mental illnesses including, but are not limited to, attention deficit hyperactivity disorder, anxiety disorders, and depression. The reason for the high rates of smoking in patients with mental illnesses may relate to attempts to self-medicate with nicotine. While nicotine may alleviate the symptoms of mental disorders, nicotine abstinence has been shown to worsen the symptoms of these disorders. In this chapter, we review the studies from animal and human research examining the bidirectional relationship between nicotine and attention deficit hyperactivity disorder, anxiety disorders, and depression as well as studies examining the roles of specific subunits of nicotinic acetylcholine receptors (nAChRs) in the interaction between nicotine and these mental illnesses. The results of these studies suggest that activation, desensitization, and upregulation of nAChRs modulate the effects of nicotine on mental illnesses.
AI snapshot
Written from the paper’s full text.
TL;DR
This chapter reviews human and animal evidence that nicotine dependence is bidirectionally linked with ADHD, anxiety disorders, and depression, with smoking rates elevated in these psychiatric populations and nicotine often used for self-medication. It concludes that acute nicotine may transiently alleviate symptoms, but withdrawal worsens them, and nAChR subtypes such as α4β2, β2-containing, and α7 modulate these effects.
Key findings
- Smoking is elevated in psychiatric populations: nicotine addiction affects 20% of the US population, while 41% of individuals reporting past-month mental illness smoke; smoking is 45.3% in anxiety disorders versus 22.5% in the nonclinical population, and nicotine dependence is 22% in anxiety disorders versus 11.1% in the nondependent population.
- In ADHD, 42% of males and 38% of females with ADHD were smokers versus 28.1% and 23.5% without ADHD; the quit ratio was 29% versus 48.5%, and lifetime tobacco dependence was 40% versus 19%. Acute nicotine improved attention and behavioral inhibition in ADHD, but withdrawal worsened symptoms and predicted relapse.
- In anxiety/PTSD, PTSD patients who never smoked showed higher β2 nAChR density in mesiotemporal cortex; acute nicotine enhances hippocampus-dependent fear conditioning and impairs extinction, withdrawal impairs fear learning, and β2-containing nAChRs are required for these effects.
- In depression, nicotine dependence predicted a threefold risk of developing major depression, adolescent smoking was associated with a fourfold increase in later depressive symptoms, and heavy smokers had four times higher risk of depression; animal models show antidepressant-like effects of nicotine involving β2-containing and α7 nAChRs.
Methods
- Narrative review of animal and human studies examining bidirectional relationships between nicotine and ADHD, anxiety disorders, and depression, as well as roles of specific nAChR subunits.
- No primary data collection; synthesizes cited human epidemiological/clinical studies and rodent/mouse models, including fear conditioning, 5-choice serial reaction time task, forced swim test, knockout, and pharmacological studies.
- Main analysis is qualitative synthesis; no meta-analysis or statistical pooling is reported.
Limitations
- The paper states further work is needed to understand underlying mechanisms, including unresolved issues such as the neurobiological substrates and whether nicotine is sufficient to increase ADHD susceptibility; animal anxiety results are described as contradictory and varying by strain/species and task.
- The paper notes difficulty determining causality in human developmental exposure, since mothers who smoke during pregnancy may be self-medicating ADHD or subclinical ADHD symptoms, and offspring ADHD could reflect inherited risk; laboratory animal models are proposed to address this.
- Evident from the text: as a review chapter, it presents no new experimental data, and some cited findings are explicitly said to require further examination, such as the discrepancy between α7 agonist studies and α7 knockout studies on attention.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
0 of 148 cited sources checked · 0 supported · 0 flagged
- Interpretationreasoning
Activation, desensitization, and upregulation of nicotinic acetylcholine receptors modulate the effects of nicotine on mental illnesses.
“The results of these studies suggest that activation, desensitization, and upregulation of nAChRs modulate the effects of nicotine on mental illnesses.”
Quote in the paperSubstantial claim - Interpretationcitation
Smoking can worsen attention problems.
“This study suggests that smoking can worsen attention problems.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Treur et al., in press
Not checked in the free run.
- Interpretationreasoning
Smoking may be an attempt to self-medicate for symptoms of ADHD.
“Therefore, smoking may be an attempt to self-medicate for symptoms of ADHD.”
Quote in the paperSubstantial claim - Premisenone given
Nicotine abstinence has been shown to worsen the symptoms of mental disorders.
“While nicotine may alleviate the symptoms of mental disorders, nicotine abstinence has been shown to worsen the symptoms of these disorders.”
Quote in the paperSubstantial claim - Premisecitation
Both male and female smokers with ADHD had a greater level of nicotine dependence than smokers without ADHD.
“Furthermore, another study found that both male and female smokers with ADHD had a greater level of nicotine dependence than smokers without ADHD (Wilens et al., 2008).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Wilens et al., 2008 source
Not checked in the free run.
- Premisecitation
Lifetime tobacco dependence was 40% in individuals with ADHD compared with 19% in others.
“Lambert and Hartsough (1998) found lifetime tobacco dependence was 40% in individuals with ADHD compared to 19%.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Lambert and Hartsough (1998)
Not checked in the free run.
- Premisenone given
Nicotine dependence shows high comorbidity with mental illnesses including attention deficit hyperactivity disorder, anxiety disorders, and depression.
“Moreover, nicotine dependence shows high comorbidity with many mental illnesses including, but are not limited to, attention deficit hyperactivity disorder, anxiety disorders, and depression.”
Quote in the paperSubstantial claim - Premisecitation
The quit ratio was substantially lower in individuals with ADHD than in the non-mentally ill population, 29% versus 48.5%.
“Furthermore, the same study found that the quit ratio was substantially lower in individuals with ADHD compared to the rest of the non-mentally ill population, 29% versus 48.5%, respectively.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Pomerleau, Downey, Stelson, & Pomerleau, 1995
Not checked in the free run.
- Premisecitation
ADHD predicted future smoking and the transition into associated nicotine addiction.
“For example, ADHD predicted future smoking and the transition into associated nicotine addiction (Fuemmeler, Kollins, & McClernon, 2007)”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Fuemmeler, Kollins, & McClernon, 2007
Not checked in the free run.
- Premisecitation
Acute nicotine administered via the patch improved attention in adults and young adults with ADHD.
“Acute nicotine administered via the patch improved attention in adults and young adults with ADHD (Levin et al., 1996; Potter & Newhouse, 2008).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites Levin et al., 1996 source
Not checked in the free run.
- cites Potter & Newhouse, 2008
Not checked in the free run.
- Interpretationcitation
Individuals with mental illness and/or cognitive impairments may be at increased risk of smoking.
“Increasing evidence suggests individuals with mental illness and/or cognitive impairments may be at increased risk of smoking.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Lasser et al., 2000 source
Not checked in the free run.
- Interpretationreasoning
Complete absence of α7 nAChRs could alter attention, possibly through changes during development or other compensatory changes that affect attention in adulthood.
“Thus, even though α7 agonists were without effect on attention (Grottick & Higgins, 2000; Young et al., 2013), the complete absence of α7 nAChRs could alter attention, possibly through changes during development or other compensatory changes that affect attention in adulthood.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites Grottick & Higgins, 2000
Not checked in the free run.
- cites Young et al., 2013 source
Not checked in the free run.
- Premisecitation
Osmotic controlled-release methylphenidate for 11 weeks in adult smokers with severe ADHD promoted abstinence in part by improving ADHD symptoms.
“In addition, another study found that osmotic controlled-release delivery of methylphenidate for 11 weeks to adult smokers with severe ADHD promoted abstinence to smoking in these individuals in part by improving ADHD symptoms (Nunes et al., 2013).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Nunes et al., 2013 source
Not checked in the free run.
- Interpretationreasoning
Attentional impairments observed in ADHD subjects might occur as a consequence of disruption in cholinergic signaling.
“Therefore, attentional impairments observed in ADHD subjects might occur as a consequence of disruption in cholinergic signaling.”
Quote in the paperSubstantial claim - Premisecitation
Anxiety disorders are significantly more prevalent in people diagnosed with nicotine dependence (22%) than in the nondependent population (11.1%).
“On the other hand, anxiety disorders have also been shown to be significantly more prevalent in the people diagnosed with nicotine dependence (22%) than in the nondependent population (11.1%; Grant, Hasin, Chou, Stinson, & Dawson, 2004; Grant, Stinson, et al., 2004).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites Grant, Hasin, Chou, Stinson, & Dawson, 2004
Not checked in the free run.
- cites Grant, Stinson, et al., 2004
Not checked in the free run.
- Premisecitation
Methylphenidate reduced smoking in adolescents.
“Methylphenidate is a stimulant commonly used to treat ADHD, and in adolescents, methylphenidate was also shown to reduce smoking (Hammerness et al., 2013; Schoenfelder, Faraone, & Kollins, 2014).”
Quote in the paperSubstantial claim0 of 2 sources checked - Interpretationreasoning
Treating nicotine addiction in individuals with ADHD may be more challenging.
“The studies reviewed so far demonstrate a clear relationship between smoking and ADHD and suggest treating nicotine addiction in individuals with ADHD may be more challenging.”
Quote in the paperSubstantial claim - Interpretationcitation
Prenatal nicotine exposure may alter nAChR function.
“Prenatal nicotine exposure may also alter nAChR function.”
Quote in the paperSubstantial claim - Interpretationcitation
Prenatal nicotine exposure may produce epigenetic changes that result in trans-generational inheritance of ADHD symptoms.
“Prenatal nicotine exposure may produce epigenetic changes that result in trans-generational inheritance of ADHD symptoms (Zhu, Lee, Spencer, Biederman, & Bhide, 2014).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Zhu, Lee, Spencer, Biederman, & Bhide, 2014
Not checked in the free run.
- Interpretationcitation
A bidirectional link exists between nicotine dependence and anxiety disorders.
“Numerous studies have identified a bidirectional link between nicotine dependence and anxiety disorders (Breslau, Davis, & Schultz, 2003; Breslau et al., 2004; Feldner, Babson, & Zvolensky, 2007; Fu et al., 2007; Koenen et al., 2005).”
Quote in the paperSubstantial claim0 of 3 sources checked- cites Breslau, Davis, & Schultz, 2003
Not checked in the free run.
- cites Breslau et al., 2004 source
Not checked in the free run.
- cites Feldner, Babson, & Zvolensky, 2007
Not checked in the free run.
- Premisecitation
Acutely administered methylphenidate increased smoking in adult ADHD subjects.
“However, a study by Vansickel, Stoops, Glaser, Poole, and Rush (2011) reported that acutely administered methylphenidate increased smoking in adult ADHD subjects.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Vansickel, Stoops, Glaser, Poole, and Rush (2011)
Not checked in the free run.
- Premisecitation
Smoking rates are significantly higher in the population with anxiety disorders than in the nonclinical population, 45.3% versus 22.5%.
“Specifically, smoking rates have been shown to be significantly higher in the population with anxiety disorders than it is in the nonclinical population, 45.3% and 22.5%, respectively (Lasser et al., 2000; Ziedonis et al., 2008).”
Quote in the paperNot a substantial claim0 of 2 sources checked - Interpretationcitation
Cholinergic signaling via α4β2 nAChRs is critically involved in the effects of nicotine on attention.
“As found in the Shoaib and Bizarro (2005) study, multiple studies suggest that cholinergic signaling via α4β2 nAChRs is critically involved in the effects of nicotine on attention.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Shoaib and Bizarro (2005)
Not checked in the free run.
- Interpretationcitation
β2-containing nAChRs may play an important role in the epidemiology of PTSD.
“These results suggest that β2-containing nAChRs may play an important role in the epidemiology of PTSD.”
Quote in the paperSubstantial claim - Interpretationcitation
Nicotine enhances hippocampal-dependent fear memories through activation of β2-containing nAChRs.
“These results suggest that nicotine enhances hippocampal-dependent fear memories through activation of β2-containing nAChRs.”
Quote in the paperSubstantial claim - Premisecitation
PTSD patients who never smoked showed significantly higher β2 nAChR density in the mesiotemporal cortex including the amygdala and hippocampus compared to healthy individuals who never smoked.
“Czermak et al. (2008) found that PTSD patients who never smoked showed significantly higher β2 nAChR density in the mesiotemporal cortex including the amygdala and hippocampus compared to healthy individuals who never smoked.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Czermak et al. (2008) source
Not checked in the free run.
- Premisecitation
β2 nAChR knockout animals did not show withdrawal deficits in contextual fear learning.
“Portugal, Kenney, and Gould (2008) found that β2 nAChR KO animals also did not show withdrawal deficits in contextual fear learning.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Portugal, Kenney, and Gould (2008)
Not checked in the free run.
- Interpretationcitation
The effects of nicotine on hippocampus-dependent fear memories require activation and upregulation of high-affinity β2-containing nAChRs.
“results from the studies using acute, chronic, and withdrawal from chronic nicotine suggest that the effects of nicotine on hippocampus-dependent fear memories require the activation and upregulation of the high-affinity β2-containing nAChRs.”
- Also stated in: § 3.2 Effects of Nicotine on Animal Models of Anxiety Disorders · hedged
“Evidence from the animal studies also suggests that the effects of nicotine on hippocampus-dependent fear memories require the activation and upregulation of the high-affinity β2-containing nAChRs (Davis & Gould, 2006, 2007, 2009; Davis et al., 2007; Kenney, Raybuck, & Gould, 2012; Portugal et al., 2008; Raybuck & Gould, 2009).”
Quote in the paperSubstantial claim0 of 3 sources checked- cites Czermak et al., 2008 source
Not checked in the free run.
- cites Davis & Gould, 2006, 2007, 2009
Not checked in the free run.
- cites Kenney, Raybuck, & Gould, 2012
Not checked in the free run.
- Also stated in: § 3.2 Effects of Nicotine on Animal Models of Anxiety Disorders · hedged
- Premisecitation
PTSD patients have difficulty learning safety discrimination.
“as well as difficulty learning safety discrimination, another form of inhibitory learning where the subjects are trained to differentiate between a safe versus dangerous cue or context (Jovanovic, Kazama, Bachevalier, & Davis, 2012; Jovanovic et al., 2010, 2009; Lissek et al., 2005; for a review, see Christianson et al., 2012).”
Quote in the paperNot a substantial claim0 of 3 sources checked - Premisecitation
PTSD patients show impaired fear extinction.
“PTSD patients show impaired fear extinction (Blechert, Michael, Vriends, Margraf, & Wilhelm, 2007; Michael, Blechert, Vriends, Margraf, & Wilhelm, 2007; Milad et al., 2009)”
Quote in the paperSubstantial claim0 of 3 sources checked - Premisecitation
Infusions of the high-affinity nAChR antagonist DhβE into the dorsal hippocampus precipitated withdrawal deficits in contextual and trace fear learning.
“infusions of the high-affinity nAChR antagonist DhβE into the dorsal hippocampus precipitated withdrawal deficits in both contextual (Davis & Gould, 2009) and trace fear learning (Raybuck & Gould, 2009).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites Davis & Gould, 2009 source
Not checked in the free run.
- cites Raybuck & Gould, 2009
Not checked in the free run.
- Premisecitation
Subcutaneous acute nicotine at 0.1 mg/kg increased anxiety-like behavior in the elevated plus maze 30 minutes after injection.
“Irvine et al. (2001) found that subcutaneous injections of acute nicotine (0.1 mg/kg) increased anxiety-like behavior in the EPM 30 min after injection.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Irvine et al. (2001) source
Not checked in the free run.
- Premisecitation
Higher doses of acute nicotine at 0.5 and 1 mg/kg administered intraperitoneally produced increased anxiety in the elevated plus maze.
“Ouagazzal et al. (1999) showed that higher doses of acute nicotine (0.5 and 1 mg/kg) administered intraperitoneally (i.p.) also produced increased anxiety in the EPM.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Ouagazzal et al. (1999) source
Not checked in the free run.
- Premisecitation
Contextual fear extinction requires direct involvement of the hippocampus.
“which, unlike cued extinction, requires direct involvement of the hippocampus (Tronson et al., 2009).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Tronson et al., 2009 source
Not checked in the free run.
- Premisecitation
Acute nicotine impaired contextual safety discrimination.
“Kutlu et al. (2014) examined the role of nicotine on contextual safety discrimination and found that acute nicotine impaired this form of safety learning.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Kutlu et al. (2014)
Not checked in the free run.
- Premisecitation
PTSD symptoms resurface during abstinence.
“they resurface during abstinence (Dedert et al., 2011).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Dedert et al., 2011 source
Not checked in the free run.
- Interpretationreasoning
Acute nicotine may enhance recovery and extinction of cued fear conditioning by strengthening encoding and facilitating new inhibitory learning during acquisition and extinction.
“This suggests that acute nicotine may enhance recovery and extinction of cued fear conditioning by potentially strengthening encoding and facilitating new inhibitory learning during acquisition and extinction, respectively.”
Quote in the paperSubstantial claim - Interpretationreasoning
Nicotine may make treatment of PTSD harder by further impairing safety learning.
“these results suggest that nicotine may make treatment of PTSD even harder by further impairing this type of learning.”
- Also stated in: § 3.2 Effects of Nicotine on Animal Models of Anxiety Disorders · hedged
“In summary, these studies suggest that nicotine may cause further disruption of the already impaired safety learning in PTSD patients.”
Quote in the paperSubstantial claim - Also stated in: § 3.2 Effects of Nicotine on Animal Models of Anxiety Disorders · hedged
- Interpretationcitation
Withdrawal from chronic nicotine results in impaired hippocampus-dependent fear learning.
“multiple studies have also shown that withdrawal from chronic nicotine results in impaired hippocampus-dependent fear learning.”
Quote in the paperSubstantial claim - Interpretationreasoning
The effects of nicotine and nicotinic agents on anxiety-related paradigms are somewhat contradicting.
“The effects of nicotine and nicotinic agents on anxiety-related paradigms are somewhat contradicting (Table 1).”
Quote in the paperNot a substantial claim - Premisecitation
PTSD symptoms are reduced during nicotine intake.
“while PTSD symptoms are reduced during nicotine intake (Beckham et al., 2005; Feldner et al., 2007; Greenberg et al., 2012; Thorndike et al., 2006)”
Quote in the paperSubstantial claim0 of 3 sources checked - Interpretationreasoning
Acute nicotine administration during nicotine withdrawal results in greater enhancement of fear learning than acute administration alone.
“acute nicotine administration during nicotine withdrawal results in even greater enhancement of fear learning than acute administration alone.”
Quote in the paperSubstantial claim - Interpretationreasoning
Abstinence from nicotine may worsen the conditions of PTSD patients.
“these results indicate that abstinence from nicotine may worsen the conditions of the PTSD patients.”
Quote in the paperSubstantial claim - Premisecitation
Acute nicotine impaired contextual fear extinction.
“Kutlu and Gould (2014) showed that acute nicotine impaired contextual fear extinction”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Kutlu and Gould (2014)
Not checked in the free run.
- Interpretationreasoning
During withdrawal from chronic nicotine, the cholinergic system becomes hypersensitive to the enhancing effects of acute nicotine.
“This suggests that during withdrawal from chronic nicotine administration, the cholinergic system becomes hypersensitive to the enhancing effects of acute nicotine.”
Quote in the paperSubstantial claim - Premisecitation
Most PTSD patients reinitiate smoking to alleviate their symptoms.
“Therefore, most PTSD patients reinitiate smoking to alleviate their symptoms (Beckham et al., 2012).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Beckham et al., 2012 source
Not checked in the free run.
- Premisecitation
Intraperitoneal injections of nicotine decreased anxiety as measured in the elevated plus maze.
“O’Neill and Brioni (1994) found that i. p. injections of nicotine decreased anxiety as measured in the EPM paradigm.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites O’Neill and Brioni (1994)
Not checked in the free run.
- Interpretationcitation
Sustained nAChR activity is required for the anxiolytic effect of ABT-418.
“which suggests that sustained nAChR activity is required for the anxiolytic effect of ABT-418.”
Quote in the paperSubstantial claim - Premisecitation
α7 nAChR-lacking knockout mice show decreased levels of anxiety in the elevated plus maze.
“Paylor et al. (1998) showed that α7 nAChR-lacking KO mice show decreased levels of anxiety in the EPM paradigm”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Paylor et al. (1998) source
Not checked in the free run.
- Premisecitation
Subcutaneous acute nicotine at 0.35 mg/kg significantly increased open arm duration in rats.
“Ericson et al. (2000) found that subcutaneous acute nicotine administration (0.35 mg/kg) significantly increased open arm duration in rats.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Ericson et al. (2000) source
Not checked in the free run.
- Premisecitation
Selective elimination of α4β2 nAChRs located on dopaminergic neurons reversed the anxiolytic effects of nicotine.
“McGranahan, Patzlaff, Grady, Heinemann, and Booker (2011) found that selective elimination of α4β2 nAChRs located on dopaminergic neurons reversed the anxiolytic effects of nicotine.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites McGranahan et al. (2011) source
Not checked in the free run.
- Premisecitation
α5 knockout animals showed altered hypothalamus-pituitary-adrenal axis function with lower basal corticosterone levels.
“Gangitano, Salas, Teng, Perez, and De Biasi (2009) demonstrated that α5 KO animals showed altered hypothalamus–pituitary–adrenal axis function as they were shown to have lower basal corticosterone levels.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Gangitano et al. (2009) source
Not checked in the free run.
- Premisecitation
The anxiolytic effects of ABT-418 were reversed by the nAChR antagonist mecamylamine.
“Brioni et al. (1994) also showed that the anxiolytic effects of ABT-418 were reversed by the nAChR antagonist mecamylamine”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Brioni et al. (1994) source
Not checked in the free run.
- Interpretationcitation
Several nAChR subtypes play modulatory roles in anxiety-like behavior.
“Several nAChR subtypes have been identified to play modulatory roles in the anxiety-like behavior.”
Quote in the paperSubstantial claim - Interpretationreasoning
The contradicting effects of nicotine reported by different studies may be explained by the different species and strains used.
“The contradicting effects of nicotine reported by different studies may also be explained by the different species and strains used in these experiments.”
Quote in the paperNot a substantial claim - Interpretationreasoning
In animals, nicotine has differential effects on anxiety in different strains/species and anxiety-related animal models.
“Overall, these results suggest that in animals, nicotine has differential effects on anxiety in different strains/species and anxiety-related animal models.”
Quote in the paperSubstantial claim - Premisecitation
Genetically modified mice lacking the β2 subtype of nAChRs showed normal levels of anxiety in the elevated plus maze.
“genetically modified mice that lack β2 subtype of nAChRs showed normal levels of anxiety in the EPM (Picciotto et al., 1998)”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Picciotto et al., 1998 source
Not checked in the free run.
- Premisecitation
Nicotine injections 5 minutes before the elevated plus maze test had an anxiolytic effect after 7 days of repeated administration.
“Irvine et al. (2001) also found that injections 5 min before the EPM test had an anxiolytic effect after 7 days of repeated administration.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Irvine et al. (2001) source
Not checked in the free run.
- Interpretationcitation
β2-containing nAChRs mediate nicotine's effects on anxiety.
“there is evidence that β2-containing nAChRs mediate nicotine’s effects on anxiety.”
Quote in the paperSubstantial claim - Premisecitation
Desensitization of α7 nAChRs by the α7 partial agonist ABT-107 reversed the anxiogenic effects of nicotine withdrawal.
“desensitization of α7 nAChRs by using an α7 partial agonist, ABT-107, was found to reverse the anxiogenic effects of nicotine withdrawal (Yohn et al., 2014).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Yohn et al., 2014 source
Not checked in the free run.
- Premisecitation
The α7-selective agonist PNU-282987 increased anxiety in the open field paradigm.
“an α7-selective agonist, PNU-282987, was shown to increase anxiety in the OF paradigm (Pandya & Yakel, 2013).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Pandya & Yakel, 2013
Not checked in the free run.
- Interpretationreasoning
Acute nicotine may have differential effects on different anxiety paradigms.
“This shows that acute nicotine may have differential effects on different anxiety paradigms.”
Quote in the paperSubstantial claim - Premisecitation
α4 knockout mice showed increased anxiety in the elevated plus maze.
“α4 KO mice showed increased anxiety in the same paradigm (Labarca et al., 2001; Ross et al., 2000).”
Quote in the paperSubstantial claim0 of 2 sources checked - Premisecitation
The anxiogenic effects of nicotine withdrawal are reversed by acute nicotine challenge.
“The anxiogenic effects of nicotine withdrawal have also been shown to be reversed by acute nicotine challenge (Ericson et al., 2000).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Ericson et al., 2000 source
Not checked in the free run.
- Interpretationcitation
Vulnerability for depression increases with higher rates of smoking.
“which suggests that the vulnerability for depression increases with higher rates of smoking.”
Quote in the paperSubstantial claim - Premisecitation
β4 knockout animals showed higher heart rate in the social isolation anxiety paradigm.
“However, β4 KO animals showed higher heart rate in another anxiety paradigm, social isolation.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Salas et al. (2003) source
Not checked in the free run.
- Premisecitation
Depression and nicotine dependence have a reciprocal relationship.
“depression and nicotine dependence have also a reciprocal relationship (Ischaki & Gratziou, 2009; John, Meyer, Rumpf, & Hapke, 2004).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites Ischaki & Gratziou, 2009
Not checked in the free run.
- cites John, Meyer, Rumpf, & Hapke, 2004
Not checked in the free run.
- Premisecitation
Nicotine dependence predicted a threefold risk of developing major depression.
“nicotine dependence, as defined in Diagnostic and Statistical Manual of Mental Disorders, Revised Third Edition, predicted a threefold risk of developing major depression (Breslau & Johnson, 2000)”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Breslau & Johnson, 2000
Not checked in the free run.
- Premisecitation
Patients with major depression increased smoking when they experienced depressive symptoms.
“patients with major depression increased smoking when they experienced depressive symptoms (Schleicher, Harris, Catley, & Nazir, 2009).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Schleicher et al., 2009 source
Not checked in the free run.
- Interpretationreasoning
Results from animal models of anxiety are less conclusive because the effects of nicotine on anxiety-related behavior vary based on the strains/species and the task used.
“However, the results from the studies using animal models of anxiety are less conclusive as the effects of nicotine on anxiety-related behavior in animals vary based on the strains/species and the task used in the study.”
Quote in the paperSubstantial claim - Interpretationcitation
The studies cited reveal a strong bidirectional relationship between nicotine, anxiety, and fear learning.
“In summary, the studies cited above reveal a strong bidirectional relationship between nicotine, anxiety, and fear learning.”
Quote in the paperSubstantial claim - Interpretationreasoning
Anxiety measured in different animal models may have different underlying neurobiological and genetic mechanisms.
“This suggests that anxiety measured in different animal models may actually have different underlying neurobiological and genetic mechanisms.”
Quote in the paperSubstantial claim - Interpretationreasoning
In addition to β2 and α7, anxiety phenotypes are controlled by a variety of different nAChRs.
“These studies suggest that in addition to the involvement of the major nAChR subtypes such as β2 and α7, anxiety phenotypes are controlled by a variety of different nAChRs.”
Quote in the paperSubstantial claim - Premisecitation
The relationship between nicotine dependence and major depression is maintained across adolescents, adults, and adults over age 60.
“this relationship was maintained across different age groups such as adolescents (Killen et al., 2004), adults (Fergusson et al., 2003), and adults over age 60 (Glassman, Covey, Stetner, & Rivelli, 2001).”
Quote in the paperNot a substantial claim0 of 3 sources checked - Premisecitation
Smoking during adolescence results in a fourfold increase in the likelihood of developing depressive symptoms later in life.
“smoking during adolescence results in a fourfold increase in the likelihood of developing depressive symptoms later in life (Brook, Schuster, & Zhang, 2004; Choi, Patten, Gillin, Kaplan, & Pierce, 1997; Goodman & Capitman, 2000; Wu & Anthony, 1999).”
Quote in the paperNot a substantial claim0 of 3 sources checked - Premisecitation
A majority of smokers enrolled in smoking cessation programs have a history of depressive episodes.
“a majority of smokers enrolled in smoking cessation programs have a history of depressive episodes (Dalack, Glassman, Rivelli, Covey, & Stetner, 1995; Glassman et al., 1988; Lerman et al., 1996)”
Quote in the paperSubstantial claim0 of 3 sources checked - Interpretationreasoning
Results from these studies converge on the importance of α7/α4-containing nAChRs in the effects of nicotine on anxiety.
“Nevertheless, results from these studies converge on the importance of α7/α4-containing nAChRs in the effects of nicotine on anxiety.”
Quote in the paperSubstantial claim - Premisecitation
Smokers with a history of depression failed to quit smoking twice as often as smokers without a prior depressive episode.
“those with a history of depression failed to quit smoking twice as often as smokers without a prior depressive episode (Glassman et al., 1990).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Glassman et al., 1990 source
Not checked in the free run.
- Interpretationreasoning
The discrepancy between Rollema et al. (2009) and Turner et al. (2010) results is likely due to the different mouse strains used, C57BL/6J and 129SvJ-C57BL/6J F1 hybrid mice.
“The discrepancy between Rollema et al. (2009) and Turner et al. (2010) results is likely to be due to the different mouse strains used by these two studies, C57BL/6J mice and 129SvJ-C57BL/6J F1 hybrid mice, respectively.”
Quote in the paperNot a substantial claim0 of 2 sources checked - Premisecitation
The α4β2 selective high-affinity nAChR antagonist DHβE decreases immobility in the forced swim test and tail-suspension test.
“an α4β2 selective high-affinity nAChR antagonist, DHβE, has been found to decrease immobility in the FST and tail-suspension test (Andreasen, Olsen, Wiborg, & Redrobe, 2009; Rabenstein et al., 2006).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites Andreasen et al., 2009
Not checked in the free run.
- cites Rabenstein et al., 2006 source
Not checked in the free run.
- Interpretationreasoning
β2-containing nAChRs may play an important role in modulation of depression-like behavior.
“Multiple studies have suggested that β2-containing nAChRs may play an important role in modulation of depression-like behavior.”
Quote in the paperNot a substantial claim - Premisecitation
Other nicotinic partial agonists such as sazetidine-A and ispronicline also have antidepressant effects.
“other nicotinic partial agonists such as sazetidine-A and ispronicline (TC-1734 or AZD3480) also have antidepressant effects (Gatto et al., 2004; Xiao et al., 2006).”
Quote in the paperNot a substantial claim0 of 2 sources checked - Interpretationcitation
Other nAChR subtypes, such as α5, may also be involved in the depression-related behavioral phenotype.
“Nevertheless, other nAChR subtypes, such as α5, may also be involved in the depression-related behavioral phenotype.”
Quote in the paperNot a substantial claim - Interpretationcitation
The α5 nAChR subtype may also be involved in the modulation of depressive-like behavior.
“α5 may also be involved in the modulation of depressive-like behavior.”
Quote in the paperNot a substantial claim - Premisecitation
Female but not male α5 knockout mice showed a reduced depressive-like behavioral phenotype.
“Gangitano et al. (2009) found that female but not male α5 KO mice showed reduced depressive-like behavioral phenotype.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Gangitano et al. (2009) source
Not checked in the free run.
- Premisecitation
Smokers with a history of depression are more likely to experience another depressive episode 6 months after smoking cessation.
“smokers with a history of depression have been shown to be more likely to experience another depressive episode 6 months after smoking cessation (Glassman et al., 2001).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Glassman et al., 2001 source
Not checked in the free run.
- Interpretationcitation
The α7 subtype of nAChRs may play a modulatory role in depression-like behavior in animals.
“there is also evidence showing that α7 subtype of nAChRs may also play a modulatory role in the depression-like behavior in animals.”
Quote in the paperNot a substantial claim - Interpretationreasoning
Inactivation of β2-containing nAChRs along with α7 nAChR activation results in reduction of depression-like behavior in animal models of depression.
“These studies suggest that inactivation of β2-containing nAChRs along with α7 nAChR activation results in reduction of depression-like behavior in the animal models of depression.”
Quote in the paperSubstantial claim - Premisecitation
Mecamylamine has antidepressant-like effects in the forced swim test and tail-suspension test in wild-type but not β2 knockout animals.
“mecamylamine, a nonselective nAChR antagonist, has similar antidepressant-like effects in the FST and tail-suspension test in wild-type but not in β2 KO animals (Andreasen, Nielsen, & Redrobe, 2009; Caldarone et al., 2004; Rabenstein, Caldarone, & Picciotto, 2006).”
Quote in the paperSubstantial claim0 of 3 sources checked - Premisecitation
Varenicline, a partial agonist of α4β2 nAChRs and a full α7 agonist developed to aid smoking cessation, has antidepressant effects in the forced swim test.
“varenicline, a partial agonist of the α4β2 nAChRs and a full α7 agonist developed to aid smoking cessation in humans (Mihalak, Carroll, & Luetje, 2006), has also been found to have antidepressant effects in the FST (Rollema et al., 2009).”
Quote in the paperSubstantial claim0 of 2 sources checked - Premisecitation
Numerous studies have linked nicotine and nAChR agents with the modulation of depression-like behaviors in animals.
“numerous studies have linked nicotine and nAChR agents with the modulation of depression-like behaviors in animals (see Mineur & Picciotto, 2010 for a review).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Mineur & Picciotto, 2010
Not checked in the free run.
- Interpretationreasoning
Increased severity of depression and withdrawal symptoms upon smoking cessation might contribute to lower levels of successful smoking cessation in people with depression.
“these results suggest that the increased severity of depression and withdrawal symptoms upon smoking cessation might contribute to the lower levels of successful smoking cessation in people with depression.”
Quote in the paperSubstantial claim - Premisecitation
Smoking cessation increases the severity of depression symptoms.
“smoking cessation increases the severity of depression symptoms (Covey et al., 1997; Swan, Ward, & Jack, 1996; West, Hajek, & Belcher, 1989).”
Quote in the paperSubstantial claim0 of 3 sources checked - Premisecitation
Knockout mice lacking the β2 subunit of nAChRs show decreased baseline immobility in both the forced swim test and tail-suspension test compared to wild-type animals, indicating a reduced depression-like phenotype.
“KO mice that lack the β2 subunit of nAChRs show decreased amount of baseline immobility in both the FST and tail-suspension test, indication of reduced depression-like phenotype, compared to wild-type animals (Caldarone et al., 2004).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Caldarone et al., 2004 source
Not checked in the free run.
- Interpretationreasoning
Depression is strongly affected by nicotine exposure.
“studies indicate that depression is strongly affected by nicotine exposure.”
Quote in the paperSubstantial claim - Interpretationnone given
The studies reviewed show that often acute nicotine produces effects that result in short-term reduction of symptoms associated with mental illness.
“The studies reviewed in this chapter show that often acute nicotine produces effects that result in the short-term reduction of the symptoms associated with the mental illness.”
Quote in the paperSubstantial claim - Interpretationreasoning
Partial agonists of α4β2 nAChRs such as sazetidine-A and varenicline seem to help alleviate depressive-like behavior.
“partial agonists of the α4β2 nAChRs such as sazetidine-A, and varenicline, which was developed for smoking cessation, seem to also help with the alleviation of the depressive-like behavior.”
Quote in the paperSubstantial claim - Interpretationreasoning
Patients with these disorders usually transition into chronic use of nicotine for self-medication purposes.
“Consequently, patients with these disorders usually transition into chronic use of nicotine for the self-medication purposes.”
Quote in the paperSubstantial claim - Interpretationreasoning
Patients with mental disorders usually have difficulty quitting smoking.
“there is also strong evidence suggesting that patients with mental disorders usually have difficulty quitting smoking.”
Quote in the paperSubstantial claim - Interpretationnone given
Animal models of depression showed that nicotine reduced depressive-like behavior in the forced swim test, chronic mild stress sucrose test, and learned helplessness.
“the studies utilizing animal models of depression also showed that nicotine reduced depressive-like behavior in animals in several different models of depression (e.g., FST, chronic mild stress sucrose test, and learned helplessness).”
Quote in the paperSubstantial claim - Interpretationreasoning
Nicotine's antidepressant effect seems to be modulated by β2-containing and α7 nAChRs.
“Evidence from the pharmacological inactivation studies and studies using global KO animals suggest that nicotine’s antidepressant effect seems to be modulated by the β2-containing and α7 nAChRs.”
Quote in the paperSubstantial claim - Interpretationnone given
Several subunits of nAChRs, such as α4, β2, and α7, directly modulate the severity of symptoms of mental disorders and the effects of nicotine on these symptoms.
“Several subunits of nAChRs, such as α4, β2, and α7, have been shown to directly modulate the severity of the symptoms of mental disorders and the effects of nicotine on these symptoms.”
Quote in the paperSubstantial claim - Interpretationreasoning
Results from studies using partial nAChR agonists and direct nAChR antagonists converge on the importance of nAChR desensitization in the antidepressant effects of nicotine.
“Overall, the results from the studies using partial nAChR agonist and direct nAChR antagonists converge on the importance of the nAChR desensitization in the antidepressant effects of nicotine.”
Quote in the paperSubstantial claim - Interpretationnone given
Significantly higher rates of smoking are seen in the population with mental disorders such as ADHD, anxiety disorders, and depression compared to the nonpatient population.
“The significantly higher rates of smoking are seen in the population with mental disorders such as ADHD, anxiety disorders, and depression, in comparison to the nonpatient population”
Quote in the paperSubstantial claim
- May combine two claims. 41
- Classified as probably not a substantial claim. 4
May combine two claims.
PremisecitationThe rate of smoking in individuals who reported mental illness in the past month was 41%, about double the CDC rate for the general population.
“In support, the rate of smoking in individuals that reported mental illness in the past month was 41% (Lasser et al., 2000). This is a doubling of what is reported by the CDC for the general population.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Lasser et al., 2000 source
Not checked in the free run.
May combine two claims.
InterpretationreasoningDifferences in nAChR function may contribute to increased vulnerability to nicotine addiction for individuals with ADHD, and genetics plays a role in this vulnerability.
“These studies suggest that differences in nAChR function may contribute to increased vulnerability to nicotine addiction for individuals with ADHD and that genetics plays a role in this vulnerability.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S4 (based).
Interpretationnone givenThe high rates of smoking in patients with mental illnesses may relate to attempts to self-medicate with nicotine.
“The reason for the high rates of smoking in patients with mental illnesses may relate to attempts to self-medicate with nicotine.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationForty-two percent of males with ADHD and 38% of females with ADHD were smokers, compared with 28.1% and 23.5% of males and females without ADHD.
“Forty-two percent of males with ADHD were smokers and 38% of females with ADHD were smokers; this compares to 28.1% and 23.5% smokers for males and females without ADHD (Pomerleau, Downey, Stelson, & Pomerleau, 1995).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Pomerleau, Downey, Stelson, & Pomerleau, 1995
Not checked in the free run.
May combine two claims.
InterpretationcitationA complex relationship exists between ADHD and smoking, with ADHD contributing to smoking and smoking also contributing to the development of attention deficits.
“Evidence suggests a complex relationship exists between ADHD and smoking with ADHD contributing to smoking but smoking also contributing to the development of attention deficits.”
Quote in the paperSubstantial claimMay combine two claims.
InterpretationreasoningInitially nicotine may have positive effects on cognitive/attentional control and response inhibition, but with prolonged use the positive effects disappear and cognitive functions may worsen in ADHD.
“Together, these studies suggest that initially nicotine may have positive effects on cognitive/attentional control and response inhibition but with prolonged used, the positive effects disappear and cognitive functions may worsen in ADHD.”
Quote in the paperSubstantial claimMay combine two claims.
InterpretationcitationCholinergic function is required for normal attentional processes, and modulation of cholinergic signaling alters attention.
“Together, these results provide support for the hypothesis that cholinergic function is required for normal attentional processes and that modulation of cholinergic signaling alters attention.”
Quote in the paperSubstantial claimMay combine two claims.
InterpretationreasoningPrenatal and adolescent nicotine exposure contribute to the development of ADHD.
“Collectively, these studies suggest that prenatal and adolescent nicotine exposure contribute to the development of ADHD, and thus, limiting nicotine exposure during development is of critical importance.”
Quote in the paperSubstantial claimMay combine two claims.
InterpretationreasoningNicotine dependence may increase vulnerability to anxiety disorders, while smoking may alleviate symptoms associated with anxiety disorders, which in turn increases nicotine dependence among patients with anxiety disorders.
“Therefore, it is possible that while nicotine dependence increases one’s vulnerability to anxiety disorders, smoking may serve as a mean to alleviate symptoms associated with anxiety disorders, which, in turn, increases nicotine dependence among patients with anxiety disorders.”
Quote in the paperSubstantial claimMay combine two claims.
InterpretationcitationDuring chronic nicotine administration, hippocampal nAChRs desensitize and upregulate, and the resulting hypersensitive cholinergic system may be responsible for the effects of nicotine withdrawal on hippocampus-dependent learning.
“There is also evidence suggesting that during chronic nicotine administration, hippocampal nAChRs desensitize and upregulate and the resulting hypersensitive cholinergic system may be responsible for the effects of nicotine withdrawal on hippocampus-dependent learning (Dani & Heinemann, 1996; Gould et al., 2012; Marks, Grady, & Collins, 1993; Wilkinson & Gould, 2013).”
Quote in the paperSubstantial claim0 of 3 sources checkedMay combine two claims.
PremisecitationThe presence of PTSD symptoms such as hyperarousal and emotional numbing is a predictor for nicotine dependence, and these symptoms are reduced by nicotine intake.
“Furthermore, several studies have shown that the presence of PTSD symptoms, such as hyperarousal and emotional numbing, is a predictor for nicotine dependence and these symptoms are reduced by nicotine intake (Beckham et al., 2005; Feldner et al., 2007; Greenberg et al., 2012; Thorndike, Wernicke, Pearlman, & Haaga, 2006).”
Quote in the paperSubstantial claim0 of 3 sources checkedMay combine two claims.
PremisecitationAcute nicotine enhances hippocampus-dependent contextual and trace fear conditioning, whereas it has no effect on hippocampus-independent cued fear conditioning.
“For example, there is ample evidence suggesting that acute nicotine enhances hippocampus-dependent contextual (Davis, Porter, & Gould, 2006; Gould, 2003; Gould, Feiro, & Moore, 2004; Gould & Higgins, 2003; Gould & Wehner, 1999; Wehner et al., 2004) and trace (Davis & Gould, 2007; Gould et al., 2004) fear conditioning, whereas it has no effect on hippocampus-independent cued fear conditioning (e.g.”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites Davis, Porter, & Gould, 2006
Not checked in the free run.
- cites Gould, 2003
Not checked in the free run.
- cites Davis & Gould, 2007
Not checked in the free run.
May combine two claims.
PremisecitationPrior smoking is associated with increased susceptibility to develop PTSD in the event of a trauma and with increased risk of panic attacks and development of panic disorders.
“Consistent with the high rates of nicotine dependence in patients with anxiety disorders, prior smoking has been found to be associated with increased susceptibility to develop PTSD in the event of a trauma (Koenen et al., 2005), an increased risk of panic attacks and development of panic disorders (Goodwin, Lewinsohn, & Seeley, 2005).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites Koenen et al., 2005 source
Not checked in the free run.
- cites Goodwin, Lewinsohn, & Seeley, 2005
Not checked in the free run.
May combine two claims.
PremisecitationPTSD patients showed lower rates of quitting, worse nicotine withdrawal symptoms, and shorter times to first smoking lapse than the non-PTSD population.
“PTSD patients also showed lower rates of quitting (Hapke et al., 2005; Lasser et al., 2000), suffered from worse nicotine withdrawal symptoms (Dedert et al., 2011), and as a result showed shorter times to first smoking lapse (Beckham, Calhoun, Dennis, Wilson, & Dedert, 2012) than non-PTSD population.”
Quote in the paperNot a substantial claim0 of 3 sources checkedProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationFear extinction is widely utilized as a translational animal model for exposure therapies used for anxiety disorders.
“Fear extinction has been widely utilized as a translational animal model for the exposure therapies used for anxiety disorders (Briscione et al., 2014; Myers & Davis, 2006; Quirk & Mueller, 2007).”
Quote in the paperNot a substantial claim0 of 3 sources checkedMay combine two claims.
InterpretationcitationNicotine withdrawal and tolerance are dissociable processes: rapidly developing nAChR desensitization may be responsible for tolerance effects, whereas upregulation of nAChRs is necessary for withdrawal effects.
“Therefore, this suggests that the rapidly developing nAChR desensitization may be responsible for the tolerance effects, whereas upregulation of nAChRs, which requires a longer period of time to develop, is necessary for the withdrawal effects.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Gould, Wilkinson, Yildirim, Blendy, & Adoff, 2014
Not checked in the free run.
May combine two claims.
PremisecitationAcute nicotine administered during the extinction phase enhanced extinction and impaired renewal of cued fear memories.
“Elias et al. (2010) found that acute nicotine enhanced extinction and impaired renewal of cued fear memories when administered during the extinction phase”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Elias et al. (2010) source
Not checked in the free run.
May combine two claims.
PremisecitationNicotine administration during both training and extinction phases impaired extinction and enhanced renewal of cued fear.
“whereas nicotine administration during both training and extinction phases impaired extinction and enhanced renewal of cued fear.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Elias et al. (2010) source
Not checked in the free run.
May combine two claims.
Interpretationnone givenAcute nicotine enhances acquisition and impairs extinction of hippocampus-dependent fear memories.
“numerous studies that have investigated the relationship between nicotine and fear learning suggest that acute nicotine enhances acquisition and impairs extinction of hippocampus-dependent fear memories.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationAnimal models of anxiety are widely utilized for neurobiological and pharmacological investigation of anxiety disorders.
“Animal models of anxiety have been widely utilized for the neurobiological and pharmacological investigation of the anxiety disorders (Rodgers, 1997).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Rodgers, 1997 source
Not checked in the free run.
May combine two claims.
PremisecitationPrior chronic nicotine exposure impaired cued extinction but had no effect on contextual fear.
“Tian and colleagues (2008) tested the effects of prior chronic nicotine exposure on subsequent extinction and showed that prior nicotine impaired cued extinction while having no effect of contextual fear.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Tian and colleagues (2008)
Not checked in the free run.
May combine two claims.
InterpretationcitationReinitiating smoking may enhance fear memories associated with new trauma and could prolong the course of PTSD.
“Wilkinson and Gould’s (2013) results showing increased sensitivity to the effects of reintroduction of nicotine during nicotine withdrawal suggest that it may also enhance fear memories associated with new trauma and could prolong the course of the disorder.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Wilkinson and Gould’s (2013)
Not checked in the free run.
May combine two claims.
PremisecitationLower doses of acute nicotine at 0.01 and 0.1 mg/kg had anxiolytic effects, while higher doses at 0.5 and 1.0 mg/kg had anxiogenic effects in a social interaction test.
“File, Kenny, and Ouagazzal (1998) found that lower doses of acute nicotine (0.01 and 0.1 mg/kg) also had anxiolytic effects, while higher doses (0.5 and 1.0 mg/kg) had anxiogenic effects in a social interaction test.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites File, Kenny, and Ouagazzal (1998)
Not checked in the free run.
May combine two claims.
PremisecitationRats tested 24 hours after the last nicotine injection showed increased anxiety during withdrawal, and this effect was reversed by dorsal hippocampal infusions of nicotine.
“rats tested 24 h after the last nicotine injection showed increased anxiety during withdrawal and this effect was reversed by dorsal hippocampal infusions of nicotine (Irvine et al., 2001).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Irvine et al., 2001 source
Not checked in the free run.
May combine two claims.
InterpretationcitationActivation of α7 nAChRs has an anxiogenic effect, while inactivation of these receptors via a partial α7 antagonist reverses the anxiogenic effects of nicotine withdrawal.
“while activation of α7 nAChRs has an anxiogenic effect, inactivation of these receptors via using a partial antagonist α7 reverses the anxiogenic effects of nicotine withdrawal.”
Quote in the paperSubstantial claimMay combine two claims.
InterpretationcitationElimination of β2-containing nAChRs can prevent the anxiolytic effects of nicotine, while activation of these receptors can reverse the anxiogenic effects of nicotine withdrawal.
“while elimination of β2-containing nAChRs can prevent the anxiolytic effects of nicotine, activation of these receptors can reverse the anxiogenic effects of nicotine withdrawal.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationNicotine injections 5 minutes before a social interaction test decreased social interaction, an anxiogenic effect, while injections 30 minutes before increased social interaction, an anxiolytic effect.
“Irvine et al. (1999) found that nicotine injections 5 min before the behavioral test decreased social interaction, an anxiogenic effect, while injections 30 min before the task increased social interaction, an anxiolytic effect.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Irvine et al. (1999) source
Not checked in the free run.
May combine two claims.
PremisecitationStudies finding anxiogenic effects of nicotine used male hooded Lister rats, whereas studies showing anxiolytic effects used male Wistar rats or CD1 mice.
“both Irvine et al. (1999, 2001) and Ouagazzal et al. (1999) studies, which found that nicotine has an anxiogenic effect, used male hooded Lister rats, whereas other studies showing anxiolytic effects of nicotine (Ericson et al., 2000; O’Neill & Brioni, 1994) used male Wistar rats or CD1 mice.”
Quote in the paperSubstantial claim0 of 3 sources checkedMay combine two claims.
PremisecitationThe α4β2 nAChR agonist ABT-418 increased open arm time in the elevated plus maze, and both ABT-418 and the α4β2 partial agonist ABT-089 reversed the anxiogenic effects of nicotine withdrawal.
“an α4β2 nAChR agonist, ABT-418, was found to increase open arm time in the EPM and both ABT-418 and an α4β2 nAChR partial agonist, ABT-089, reversed the anxiogenic effects of nicotine withdrawal (Brioni et al., 1994; Decker et al., 1994; Yohn, Turner, & Blendy, 2014).”
Quote in the paperSubstantial claim0 of 3 sources checkedMay combine two claims.
InterpretationcitationHuman studies suggest that smoking may alleviate symptoms associated with anxiety disorders, while nicotine abstinence worsens those symptoms and results in higher rates of reinitiation of smoking.
“While human studies suggest that smoking may alleviate the symptoms associated with anxiety disorders (Beckham et al., 2005; Feldner et al., 2007; Greenberg et al., 2012; Thorndike et al., 2006), nicotine abstinence worsens those symptoms (Dedert et al., 2011) and results in higher rates of reinitiation of smoking (Beckham et al., 2012; Hapke et al., 2005; Lasser et al., 2000).”
Quote in the paperSubstantial claim0 of 3 sources checkedMay combine two claims.
PremisecitationThe risk of developing depression was four times higher in heavy smokers than nonsmokers, and increased time of smoking dependency was correlated with increased risk of depression.
“the risk of developing depression was four times higher in heavy smokers than nonsmokers and increased time of smoking dependency was correlated with increased risk of depression (Klungsøyr, Nygård, Sørensen, & Sandanger, 2006)”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Klungsøyr et al., 2006 source
Not checked in the free run.
May combine two claims.
Premisecitationα5 knockout animals showed no behavioral changes in the open field and light-dark box paradigms, while female knockout mice, but not male mice, showed reduced anxiety-like behavior in the elevated plus maze.
“while α5 KO animals showed no behavioral changes in the OF and light–dark box paradigms, female KO mice, but not male mice, showed reduced anxiety-like behavior in the EPM.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Gangitano et al. (2009) source
Not checked in the free run.
May combine two claims.
Premisecitationβ4 knockout mice showed reduced anxiety in the elevated plus maze compared to wild-type littermates and reduced heart rate in this paradigm.
“Salas, Pieri, Fung, Dani, and De Biasi (2003) showed that β4 KO mice showed reduced anxiety in the EPM compared to WT littermates as well as reduced heart rate in this paradigm.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Salas et al. (2003) source
Not checked in the free run.
May combine two claims.
PremisecitationDepression symptoms are important determinants of smoking initiation, maintenance, and cessation, whereas nicotine dependence is associated with vulnerability for depression.
“Previous studies have shown that depression symptoms are important determinants of smoking initiation, maintenance, and cessation, whereas nicotine dependence is associated with vulnerability for depression (Breslau, Kilbey, & Andreski, 1991; Fergusson, Goodwin, & Horwood, 2003; Glassman et al., 1990; Hall, Muñoz, Reus, & Sees, 1993; Morrell & Cohen, 2006; Paperwalla, Levin, Weiner, & Saravay, 200”
Quote in the paperSubstantial claim0 of 3 sources checkedMay combine two claims.
InterpretationcitationAnimal studies using fear conditioning suggest that initial acute nicotine enhances hippocampus-dependent fear learning and impairs fear extinction, whereas acute nicotine during withdrawal further enhances hippocampus-dependent fear memories, which may prolong the disorder.
“the animal studies using fear conditioning suggest that initial acute nicotine results in enhancement of hippocampus-dependent fear learning and impairment of fear extinction, whereas acute nicotine during nicotine withdrawal further enhances hippocampus-dependent fear memories, which may prolong the course of the disorder.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationSmokers show higher rates of depression, and patients with major depression have higher levels of smoking than the nonclinical population.
“Just as smokers show higher rates of depression, patients with major depression have been shown to have higher levels of smoking than the nonclinical population (Covey, Glassman, & Stetner, 1997, 1998; Fergusson et al., 2003).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites Covey et al., 1997, 1998
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites Fergusson et al., 2003 source
Not checked in the free run.
Classified as probably not a substantial claim. May combine two claims.
PremisecitationAccording to the self-medication hypothesis of nicotine dependence, nicotine reduces negative affect and works as an antidepressant.
“According to the self-medication hypothesis of nicotine dependence (Carmody, 1992; Markou, Kosten, & Koob, 1998; Pomerleau & Pomerleau, 1985), this might be because nicotine reduces negative affect and works as an antidepressant.”
Quote in the paperSubstantial claim0 of 3 sources checkedMay combine two claims.
PremisecitationVarenicline increases nAChR activity and maintains it at a submaximal level, prevents binding of endogenous acetylcholine, and effectively desensitizes nAChRs.
“varenicline increases nAChR activity and maintains it at a submaximal level, and therefore, it prevents binding of the endogenous acetylcholine and effectively desensitizes nAChRs (Mineur & Picciotto, 2010; Papke & Heinemann, 1994).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites Mineur & Picciotto, 2010
Not checked in the free run.
- cites Papke & Heinemann, 1994
Not checked in the free run.
May combine two claims.
PremisecitationMLA, an α7-nAChR selective antagonist, reduced immobility in the forced swim test, while mecamylamine had antidepressant effects in the forced swim test for wild-type but not α7-nAChR knockout mice.
“Andreasen, Olsen, et al. (2009) found that MLA (α7-nAChR selective antagonist) also reduced immobility in the FST, while another study found that mecamylamine had antidepressant effects in the FST for wild-type but not on α7-nAChR KO mice.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Andreasen, Olsen, et al. (2009)
Not checked in the free run.
May combine two claims.
PremisecitationSazetidine-A, but not varenicline, decreased immobility in the forced swim test and tail-suspension test measures of depression.
“Turner, Castellano, and Blendy (2010) reported that sazetidine-A, but not varenicline, decreased immobility in the FST and tail-suspension test measures of depression.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Turner et al. (2010) source
Not checked in the free run.
May combine two claims.
PremisecitationNicotine had an antidepressant effect in the forced swim test, the chronic mild stress sucrose test, and learned helplessness.
“nicotine had an antidepressant effect in the forced swim test (Andreasen & Redrobe, 2009; Suemaru et al., 2006; Tizabi, Getachew, Rezvani, Hauser, & Overstreet, 2009, Tizabi et al., 1999; Vázquez-Palacios, Bonilla-Jaime, & Velázquez-Moctezuma, 2005), the chronic mild stress sucrose test (Andreasen, Henningsen, Bate, Christiansen, & Wiborg, 2011), and learned helplessness (Semba, Mataki, Yamada, N”
Quote in the paperSubstantial claim0 of 3 sources checkedMay combine two claims.
InterpretationcitationHuman studies suggest that initially smoking may alleviate symptoms of depression and works as self-medication, whereas smoking cessation results in exacerbation of depressive symptoms.
“The human studies cited suggest that initially smoking may alleviate symptoms of depression and works as a mean to self-medicate, whereas smoking cessation results in the exacerbation of the depressive symptoms.”
Quote in the paperNot a substantial claimMay combine two claims.
InterpretationreasoningSymptoms of the disorders usually worsen during withdrawal, resulting in shorter periods of abstinence and eventually reinitiation of smoking.
“This is because the symptoms of the disorders usually worsen during the period of withdrawal, which results in shorter period of abstinence and eventually reinitiation of smoking.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationParental lines of the 129SvJ-C57BL/6J F1 hybrid mice show differences in motor function, anxiety-related behavior, and sensorimotor responsivity, which may contribute to differential effects of partial nAChR agonists on depression-like behavior.
“previous research showed that the parental lines of the 129SvJ-C57BL/6J F1 hybrid mice show differences in motor function, anxiety-related behavior, and sensorimotor responsivity, which may contribute to the differential effects of partial nAChR agonists on depression-like behavior (Tarantino, Gould, Druhan, & Bucan, 2000).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Tarantino et al., 2000 source
Not checked in the free run.
The paper relies on this without support.
Findings from animal models of nicotine exposure and nAChR function can be generalized to human psychiatric disorders such as ADHD and anxiety disorders.
“Studies of laboratory animals can address these issues.”
“Laboratory animal models provide a means to address these issues.”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
α4 knockout claim cites a point-mutant study
MinorThe text cites Labarca et al. (2001) in support of increased anxiety in α4 knockout mice, but its reference entry describes mice with a hypersensitive α4 point mutation, not an α4 knockout.
“α4 KO mice showed increased anxiety in the same paradigm (Labarca et al., 2001; Ross et al., 2000).”
“115. Labarca C Schwarz J Deshpande P Schwarz S Nowak MW Fonck C 2001 Point mutant mice with hypersensitive α4 nicotinic receptors show dopaminergic deficits and increased anxiety”
β2 knockout claim cites an α2 deletion study
MinorThe text cites Lotfipour et al. (2013) for a finding about mice lacking β2 receptors, but the cited reference describes deletion of the α2 subunit gene.
“animals lacking β2 nAChRs did not show enhancement of contextual (Davis & Gould, 2007) or trace fear conditioning (Davis & Gould, 2007; Lotfipour et al., 2013) by nicotine.”
“126. Lotfipour S Byun JS Leach P Fowler CD Murphy NP Kenny PJ 2013 Targeted deletion of the mouse α2 nicotinic acetylcholine receptor subunit gene (Chrna2) potentiates nicotine-modulated behaviors”
Cites
Kessler, R. C., Chiu, W. T., Demler, O., & Walters, E. E. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.6.617 · Cited by 12,052 · see citing works
Kessler, R. C., Adler, L., Barkley, R., Biederman, J., Conners, C. K., Demler, O., Faraone, S. V., Greenhill, L. L., Howes, M. J., Secnik, K., et al. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.4.716 · Cited by 3,886 · see citing works
Differential contribution of amygdala and hippocampus to cued and contextual fear conditioning.
Phillips, R. G., & LeDoux, J. E. (1992) · Behavioral Neuroscience · doi:10.1037/0735-7044.106.2.274 · Cited by 3,292 · see citing works
Differential contribution of amygdala and hippocampus to cued and contextual fear conditioning.
Phillips, R. G., & LeDoux, J. E. (1992) · Behavioral Neuroscience · doi:10.1037//0735-7044.106.2.274 · Cited by 3,262 · see citing works
Grant, B. F., Stinson, F. S., Dawson, D. A., Chou, S. P., Dufour, M. C., Compton, W., Pickering, R. P., & Kaplan, K. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.8.807 · Cited by 2,889 · see citing works
Smoking and Mental Illness: A Population-Based Prevalence Study
Lasser, K., Boyd, J. W., Woolhandler, S., Himmelstein, D. U., McCormick, D., & Bor, D. H. (2000) · JAMA · doi:10.1001/jama.284.20.2606 · Cited by 2,508 · see citing works
Effects of an expanding-spaced vs massed exposure schedule on fear reduction and return of fear
Rowe, M. K., & Craske, M. G. (1998) · Behaviour Research and Therapy · doi:10.1016/s0005-7967(97)10016-x · Cited by 1,778 · see citing works
Neural Mechanisms of Extinction Learning and Retrieval
Quirk, G. J., & Mueller, D. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301555 · Cited by 1,645 · see citing works
Neurobiological Basis of Failure to Recall Extinction Memory in Posttraumatic Stress Disorder
Milad, M. R., Pitman, R. K., Ellis, C. B., Gold, A. L., Shin, L. M., Lasko, N. B., Zeidan, M. A., Handwerger, K., Orr, S. P., & Rauch, S. L. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.06.026 · Cited by 1,339 · see citing works
Picciotto, M. R., Zoli, M., Rimondini, R., Léna, C., Marubio, L. M., Pich, E. M., Fuxe, K., & Changeux, J.-P. (1998) · Nature · doi:10.1038/34413 · Cited by 1,320 · see citing works
Myers, K. M., & Davis, M. (2007) · Molecular Psychiatry · doi:10.1038/sj.mp.4001939 · Cited by 1,277 · see citing works
Grant, B. F., Hasin, D. S., Chou, S. P., Stinson, F. S., & Dawson, D. A. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.11.1107 · Cited by 1,262 · see citing works
The economic burden of anxiety disorders in the 1990s
Greenberg, P. E., Sisitsky, T., Kessler, R. C., Finkelstein, S. N., Berndt, E. R., Davidson, J. R. T., Ballenger, J. C., & Fyer, A. J. (1999) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v60n0702 · Cited by 1,242 · cited 2× · see citing works
“1%; Kessler, 1997; Kessler, Chiu, Demler, & Walters, 2005) and costs more than $42 billion a year, almost one-third of the United States $148 billion total mental health costs (Greenberg et al., 1999).”
BackgroundInfluentialTobacco Use Among Middle and High School Students — United States, 2011–2015
Singh, T., Arrazola, R. A., Corey, C. G., Husten, C. G., Neff, L. J., Homa, D. M., & King, B. A. (2016) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6514a1 · Cited by 1,240 · see citing works
Smoking, smoking cessation, and major depression
Glassman, A. H. (1990) · JAMA · doi:10.1001/jama.1990.03450120058029 · Cited by 1,207 · see citing works
Amygdala, medial prefrontal cortex, and hippocampal function in PTSD
SHIN, L. M., RAUCH, S. L., & PITMAN, R. K. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1364.007 · Cited by 1,203 · see citing works
Classical conditioning and brain systems: the role of awareness
Clark, R. E., & Squire, L. R. (1998) · Science · doi:10.1126/science.280.5360.77 · Cited by 1,138 · see citing works
Classical fear-conditioning in the anxiety disorders: a meta-analysis
Lissek, S., Powers, A. S., McClure, E. B., Phelps, E. A., Woldehawariat, G., Grillon, C., & Pine, D. S. (2005) · Behaviour Research and Therapy · doi:10.1016/j.brat.2004.10.007 · Cited by 1,034 · see citing works
Mineka, S., & Zinbarg, R. (2006) · American Psychologist · doi:10.1037/0003-066x.61.1.10 · Cited by 929 · see citing works
Ethologically-based animal models of anxiety disorders.
Lister, R. (1990) · Pharmacology and Therapeutics · doi:10.1016/0163-7258(90)90021-s · Cited by 894 · see citing works
Castellanos, F. X., Margulies, D. S., Kelly, C., Uddin, L. Q., Ghaffari, M., Kirsch, A., Shaw, D., Shehzad, Z., Di Martino, A., Biswal, B., et al. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.06.025 · Cited by 854 · see citing works
Brain connectivity related to working memory performance
Hampson, M., Driesen, N. R., Skudlarski, P., Gore, J. C., & Constable, R. T. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.3408-06.2006 · Cited by 853 · see citing works
Guidelines on nicotine dose selection for in vivo research
Matta, S. G., Balfour, D. J., Benowitz, N. L., Boyd, R. T., Buccafusco, J. J., Caggiula, A. R., Craig, C. R., Collins, A. C., Damaj, M. I., Donny, E. C., et al. (2007) · Psychopharmacology · doi:10.1007/s00213-006-0441-0 · Cited by 824 · see citing works
Neurobiological similarities in depression and drug dependence: a self-medication hypothesis
Markou, A. (1998) · Neuropsychopharmacology · doi:10.1016/s0893-133x(97)00113-9 · Cited by 767 · see citing works
Tobacco use and cessation in psychiatric disorders: National Institute of Mental Health report
Ziedonis, D., Hitsman, B., Beckham, J. C., Zvolensky, M., Adler, L. E., Audrain-McGovern, J., Breslau, N., Brown, R. A., George, T. P., Williams, J., et al. (2008) · Nicotine & Tobacco Research · doi:10.1080/14622200802443569 · Cited by 735 · see citing works
Solomon, P. R., Schaaf, E. R. V., Thompson, R. F., & Weisz, D. J. (1986) · Behavioral Neuroscience · doi:10.1037//0735-7044.100.5.729 · Cited by 724 · see citing works
Solomon, P. R., Vander Schaaf, E. R., Thompson, R. F., & Weisz, D. J. (1986) · Behavioral Neuroscience · doi:10.1037/0735-7044.100.5.729 · Cited by 724 · see citing works
Nicotine dependence, major depression, and anxiety in young adults
Breslau, N. (1991) · Archives of General Psychiatry · doi:10.1001/archpsyc.1991.01810360033005 · Cited by 634 · see citing works
Prefrontal Acetylcholine Release Controls Cue Detection on Multiple Timescales
Parikh, V., Kozak, R., Martinez, V., & Sarter, M. (2007) · Neuron · doi:10.1016/j.neuron.2007.08.025 · Cited by 623 · see citing works
Self-citationMolecular and cellular aspects of nicotine abuse
Dani, J. A., & Heinemann, S. (1996) · Neuron · doi:10.1016/s0896-6273(00)80112-9 · Cited by 605 · see citing works
Breslau, N., Davis, G. C., & Schultz, L. R. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.3.289 · Cited by 573 · see citing works
Varenicline Is a Partial Agonist at α4β2 and a Full Agonist at α7 Neuronal Nicotinic Receptors
Mihalak, K. B., Carroll, F. I., & Luetje, C. W. (2006) · Molecular Pharmacology · doi:10.1124/mol.106.025130 · Cited by 558 · see citing works
Nicotinic acetylcholine receptors: from structure to brain function
Hogg, R. C., Raggenbass, M., & Bertrand, D. (2003) · Springer eBooks · doi:10.1007/s10254-003-0005-1 · Cited by 529 · see citing works
Lanius, R. A., Williamson, P. C., Densmore, M., Boksman, K., Gupta, M. A., Neufeld, R. W., Gati, J. S., & Menon, R. S. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.11.1920 · Cited by 521 · see citing works
Heavy smokers, smoking cessation, and clonidine. Results of a double-blind, randomized trial
Glassman, A. H. (1988) · JAMA · doi:10.1001/jama.259.19.2863 · Cited by 494 · see citing works
Blechert, J., Michael, T., Vriends, N., Margraf, J., & Wilhelm, F. H. (2007) · Behaviour Research and Therapy · doi:10.1016/j.brat.2007.02.012 · Cited by 479 · see citing works
Nicotinic Cholinergic Receptor Binding Sites in the Brain: Regulation in Vivo
Schwartz, R. D., & Kellar, K. J. (1983) · Science · doi:10.1126/science.6828889 · Cited by 479 · see citing works
Impaired safety signal learning may be a biomarker of PTSD
Jovanovic, T., Kazama, A., Bachevalier, J., & Davis, M. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.02.023 · Cited by 473 · see citing works
Structural and functional diversity of native brain neuronal nicotinic receptors
Gotti, C., Clementi, F., Fornari, A., Gaimarri, A., Guiducci, S., Manfredi, I., Moretti, M., Pedrazzi, P., Pucci, L., & Zoli, M. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.05.024 · Cited by 469 · see citing works
Lambert, N. M., & Hartsough, C. S. (1998) · Journal of Learning Disabilities · doi:10.1177/002221949803100603 · Cited by 465 · see citing works
Effects of chronic nicotine infusion on tolerance development and nicotinic receptors
Marks, M. J., Burch, J. B., & Collins, A. C. (1983) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)21831-6 · Cited by 464 · see citing works
Bari, A., Dalley, J. W., & Robbins, T. W. (2008) · Nature Protocols · doi:10.1038/nprot.2008.41 · Cited by 452 · see citing works
Nicotinic receptors in the brain: correlating physiology with function
Jones, S., Sudweeks, S. N., & Yakel, J. L. (1999) · Trends in Neurosciences · doi:10.1016/s0166-2236(99)01471-x · Cited by 447 · see citing works
Impaired fear inhibition is a biomarker of PTSD but not depression
Jovanovic, T., Norrholm, S. D., Blanding, N. Q., Davis, M., Duncan, E., Bradley, B., & Ressler, K. J. (2010) · Depression and Anxiety · doi:10.1002/da.20663 · Cited by 444 · see citing works
Animal models of ‘anxiety’: Where next?
Rodgers, R. J. (1997) · Behavioural Pharmacology · doi:10.1097/00008877-199711000-00003 · Cited by 437 · cited 1× · see citing works
“Animal models of anxiety have been widely utilized for the neurobiological and pharmacological investigation of the anxiety disorders (Rodgers, 1997).”
MethodMcGaughy, J., Kaiser, T., & Sarter, M. (1996) · Behavioral Neuroscience · doi:10.1037/0735-7044.110.2.247 · Cited by 435 · see citing works
McGaughy, J. A., Kaiser, T. E., & Sarter, M. F. (1996) · Behavioral Neuroscience · doi:10.1037//0735-7044.110.2.247 · Cited by 435 · see citing works
Alternate stoichiometries of α4β2 nicotinic acetylcholine receptors
Nelson, M. E., Kuryatov, A., Choi, C. H., Zhou, Y., & Lindstrom, J. (2003) · Molecular Pharmacology · doi:10.1124/mol.63.2.332 · Cited by 422 · see citing works
Depressive Symptoms and Cigarette Smoking Among Teens
Goodman, E., & Capitman, J. (2000) · Pediatrics · doi:10.1542/peds.106.4.748 · Cited by 416 · see citing works
Nicotine effects on adults with attention-deficit/hyperactivity disorder
Levin, E. D., Conners, C. K., Sparrow, E., Hinton, S. C., Erhardt, D., Meck, W. H., Rose, J. E., & March, J. (1996) · Psychopharmacology · doi:10.1007/bf02246281 · Cited by 415 · see citing works
Milberger, S., Biederman, J., Faraone, S. V., Chen, L., & Jones, J. T. (1996) · American Journal of Psychiatry · doi:10.1176/ajp.153.9.1138 · Cited by 410 · see citing works
Strine, T. W., Mokdad, A. H., Balluz, L. S., Gonzalez, O., Crider, R. A., Berry, J. T., & Kroenke, K. (2008) · Psychiatric Services · doi:10.1176/ps.2008.59.12.1383 · Cited by 407 · see citing works
Salminen, O., Murphy, K. L., McIntosh, J. M., Drago, J., Marks, M. J., Collins, A. C., & Grady, S. R. (2004) · Molecular Pharmacology · doi:10.1124/mol.65.6.1526 · Cited by 401 · see citing works
Effects of smoking and smoking abstinence on cognition in adolescent tobacco smokers.
Jacobsen, L. K., Krystal, J. H., Mencl, W. E., Westerveld, M., Frost, S. J., & Pugh, K. R. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.10.022 · Cited by 393 · cited 2× · see citing works
“Furthermore, cognitive deficits associated with ADHD are similar to nicotine withdrawal-associated changes in cognition seen in smokers such as deficits in sustained attention, response inhibition, and working memory (Beane & Marrocco, 2004; Dovis, der Oord, Huizenga, Wiers, & Prins, 2014; Hughes, Keenan, & Yellin, 19…”
BackgroundLogue, S. F., Paylor, R., & Wehner, J. M. (1997) · Behavioral Neuroscience · doi:10.1037/0735-7044.111.1.104 · Cited by 385 · see citing works
Logue, S. F., Paylor, R. E., & Wehner, J. M. (1997) · Behavioral Neuroscience · doi:10.1037//0735-7044.111.1.104 · Cited by 379 · see citing works
Pomerlau (1984) · doi:10.1016/0149-7634(84)90007-1 · Cited by 378 · see citing works
Major depression and cigarette smoking: Results of a 21-year longitudinal study
FERGUSSON, D. M., GOODWIN, R. D., & HORWOOD, L. J. (2003) · Psychological Medicine · doi:10.1017/s0033291703008596 · Cited by 374 · see citing works
Smoking cessation and the course of major depression: A follow-up study
Glassman, A. H., Covey, L. S., Stetner, F., & Rivelli, S. (2001) · The Lancet · doi:10.1016/s0140-6736(00)05064-9 · Cited by 370 · see citing works
Nicotinic receptors in the brain. Links between molecular biology and behavior
Picciotto, M. (2000) · Neuropsychopharmacology · doi:10.1016/s0893-133x(99)00146-3 · Cited by 354 · see citing works
Cigarette smoking in adult patients diagnosed with attention deficit hyperactivity disorder
Pomerleau, O. F., Downey, K. K., Stelson, F. W., & Pomerleau, C. S. (1995) · Journal of Substance Abuse · doi:10.1016/0899-3289(95)90030-6 · Cited by 349 · see citing works
Jovanovic, T., Norrholm, S. D., Fennell, J. E., Keyes, M., Fiallos, A. M., Myers, K. M., Davis, M., & Duncan, E. J. (2009) · Psychiatry Research · doi:10.1016/j.psychres.2007.12.014 · Cited by 315 · see citing works
Marks, M. J., & Collins, A. C. (1982) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)15183-3 · Cited by 310 · see citing works
Nicotine, negative affect, and depression.
Hall, S. M., Muñoz, R. F., Reus, V. I., & Sees, K. L. (1993) · Journal of Consulting and Clinical Psychology · doi:10.1037//0022-006x.61.5.761 · Cited by 303 · see citing works
Cigarette smoking and major depression
Covey, L. S., Glassman, A. H., & Stetner, F. (1998) · Journal of Addictive Diseases · doi:10.1300/j069v17n01_04 · Cited by 302 · see citing works
Paylor, R., Nguyen, M., Crawley, J. N., Patrick, J., Beaudet, A., & Orr-Urtreger, A. (1998) · Learning & Memory · doi:10.1101/lm.5.4.302 · Cited by 298 · see citing works
Predicting smoking cessation and major depression in nicotine-dependent smokers
(2000) · American Journal of Public Health · doi:10.2105/ajph.90.7.1122 · Cited by 293 · see citing works
Severity of withdrawal symptoms as a predictor of outcome of an attempt to quit smoking
West, R. J., Hajek, P., & Belcher, M. (1989) · Psychological Medicine · doi:10.1017/s0033291700005705 · Cited by 279 · see citing works
Nicotine receptors and depression: revisiting and revising the cholinergic hypothesis
Mineur, Y. S., & Picciotto, M. R. (2010) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2010.09.004 · Cited by 277 · see citing works
Nicotine acts as a pharmacological chaperone to up-regulate human α4β2 acetylcholine receptors
Kuryatov, A., Luo, J., Cooper, J., & Lindstrom, J. (2005) · Molecular Pharmacology · doi:10.1124/mol.105.012419 · Cited by 275 · see citing works
Psychiatric disorders and stages of smoking
Breslau, N., Novak, S. P., & Kessler, R. C. (2004) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00317-2 · Cited by 274 · see citing works
Tobacco smoking and depressed mood in late childhood and early adolescence.
Wu, L. T., & Anthony, J. C. (1999) · American Journal of Public Health · doi:10.2105/ajph.89.12.1837 · Cited by 273 · see citing works
Klungsøyr, O., Nygård, J. F., Sørensen, T., & Sandanger, I. (2006) · American Journal of Epidemiology · doi:10.1093/aje/kwj058 · Cited by 269 · see citing works
Post-traumatic stress disorder and smoking: A systematic review
Fu, S. S., McFall, M., Saxon, A. J., Beckham, J. C., Carmody, T. P., Baker, D. G., & Joseph, A. M. (2007) · Nicotine & Tobacco Research · doi:10.1080/14622200701488418 · Cited by 260 · see citing works
Partial agonist properties of cytisine on neuronal nicotinic receptors containing the beta 2 subunit
Papke, R. L., & Heinemann, S. F. (1994) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09896-7 · Cited by 259 · see citing works
How Common Is Attention-Deficit/Hyperactivity Disorder?
Barbaresi, W. J., Katusic, S. K., Colligan, R. C., Pankratz, V. S., Weaver, A. L., Weber, K. J., Mrazek, D. A., & Jacobsen, S. J. (2002) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/archpedi.156.3.217 · Cited by 256 · see citing works
Decker, M. W., Brioni, J. D., Bannon, A. W., & Arnerić, S. P. (1995) · Life Sciences · doi:10.1016/0024-3205(94)00488-e · Cited by 256 · see citing works
Major depression following smoking cessation
(1997) · American Journal of Psychiatry · doi:10.1176/ajp.154.2.263 · Cited by 250 · see citing works
Grottick, A. J., & Higgins, G. A. (2000) · Behavioural Brain Research · doi:10.1016/s0166-4328(00)00305-3 · Cited by 240 · see citing works
Feldner, M. T., Babson, K. A., & Zvolensky, M. J. (2007) · Clinical Psychology Review · doi:10.1016/j.cpr.2006.08.004 · Cited by 240 · see citing works
Sonntag, H., Wïttchen, H., Höfler, M., Kessler, R. C., & Stein, M. B. (2000) · European Psychiatry · doi:10.1016/s0924-9338(00)00209-1 · Cited by 230 · see citing works
John, U., Meyer, C., Rumpf, H., & Hapke, U. (2004) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2004.06.004 · Cited by 228 · see citing works
Nicotine, negative affect, and depression.
Hall, S. M., Muñoz, R. F., Reus, V. I., et al. (1993) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.61.5.761 · Cited by 221 · see citing works
Young, J. W., Finlayson, K., Spratt, C., Marston, H. M., Crawford, N., Kelly, J. S., & Sharkey, J. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300393 · Cited by 219 · see citing works
Tobacco use among middle and high school students - United States, 2011-2014.
Arrazola, R. A., Singh, T., Corey, C. G., Husten, C. G., Neff, L. J., Apelberg, B. J., Bunnell, R. E., Choinière, C. J., King, B. A., Cox, S. N., et al. (2014) · PubMed Central · Cited by 219 · see citing works
Zwart, R., & Vijverberg, H. P. M. (1998) · Molecular Pharmacology · doi:10.1124/mol.54.6.1124 · Cited by 215 · see citing works
Milberger, S., Biederman, J., Faraone, S. V., & Jones, J. (1998) · Journal of Clinical Child Psychology · doi:10.1207/s15374424jccp2703_11 · Cited by 211 · see citing works
Fear conditioning in panic disorder: Enhanced resistance to extinction
Michael, T., Blechert, J., Vriends, N., Margraf, J., & Wilhelm, F. H. (2007) · Journal of Abnormal Psychology · doi:10.1037/0021-843x.116.3.612 · Cited by 210 · see citing works
Antidepressant effects of nicotine in an animal model of depression
Tizabi, Y., Overstreet, D. H., Rezvani, A. H., Louis, V. A., Clark Jr, E., Janowsky, D. S., & Kling, M. A. (1999) · Psychopharmacology · doi:10.1007/s002130050879 · Cited by 209 · cited 1× · see citing works
“…effect in the forced swim test (Andreasen & Redrobe, 2009; Suemaru et al., 2006; Tizabi, Getachew, Rezvani, Hauser, & Overstreet, 2009, Tizabi et al., 1999; Vázquez-Palacios, Bonilla-Jaime, & VelázquezMoctezuma, 2005), the chronic mild stress sucrose test (Andreasen, Henningsen, Bate,…”
Investigation of mechanisms linking depressed mood to nicotine dependence
Lerman, C., Audrain, J., Orleans, C. T., Boyd, R., Gold, K., Main, D., & Caporaso, N. (1996) · Addictive Behaviors · doi:10.1016/0306-4603(95)00032-1 · Cited by 209 · see citing works
Cigarette smoking predicts development of depressive symptoms among U.S. Adolescents
Choi, W. S., Patten, C. A., Christian Gillin, J., Kaplan, R. M., & Pierce, J. P. (1997) · Annals of Behavioral Medicine · doi:10.1007/bf02883426 · Cited by 208 · see citing works
Affect regulation, nicotine addiction, and smoking cessation
Carmody, T. P. (1992) · Journal of Psychoactive Drugs · doi:10.1080/02791072.1992.10471632 · Cited by 206 · see citing works
Ross, S. A., Wong, J. Y. F., Clifford, J. J., Kinsella, A., Massalas, J. S., Horne, M. K., Scheffer, I. E., Kola, I., Waddington, J. L., Berkovic, S. F., et al. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-17-06431.2000 · Cited by 204 · see citing works
Alkondon, M., & Albuquerque, E. X. (2004) · Progress in brain research · doi:10.1016/s0079-6123(03)45007-3 · Cited by 197 · see citing works
Koenen, K. C., Hitsman, B., Lyons, M. J., Niaura, R., McCaffery, J., Goldberg, J., Eisen, S. A., True, W., & Tsuang, M. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.11.1258 · Cited by 197 · see citing works
Arnold, H. M., Burk, J. A., Hodgson, E. M., Sarter, M., & Bruno, J. P. (2002) · Neuroscience · doi:10.1016/s0306-4522(02)00292-0 · Cited by 195 · see citing works
Downregulation of nicotinic receptor function after chronic nicotine infusion.
Marks, M. J., Grady, S. R., & Collins, A. C. (1993) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)39368-7 · Cited by 190 · see citing works
Hahn, B., Shoaib, M., & Stolerman, I. (2002) · Psychopharmacology · doi:10.1007/s00213-002-1005-6 · Cited by 188 · see citing works
File, S. E., Kenny, P. J., & Ouagazzal, A. (1998) · Behavioral Neuroscience · doi:10.1037//0735-7044.112.6.1423 · Cited by 181 · see citing works
Decker, M. W., Brioni, J. D., Sullivan, J. P., Buckley, M. J., Radek, R. J., Raszkiewicz, J. L., Kang, C. H., Kim, D. J., Giardina, W. J., & Wasicak, J. T. (1994) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)22339-4 · Cited by 180 · cited 1× · see citing works
“For example, an α4β2 nAChR agonist, ABT-418, was found to increase open arm time in the EPM and both ABT-418 and an α4β2 nAChR partial agonist, ABT-089, reversed the anxiogenic effects of nicotine withdrawal (Brioni et al., 1994; Decker et al., 1994; Yohn, Turner, & Blendy, 2014).”
BackgroundLabarca, C., Schwarz, J., Deshpande, P., Schwarz, S., Nowak, M. W., Fonck, C., Nashmi, R., Kofuji, P., Dang, H., Shi, W., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.041582598 · Cited by 177 · see citing works
Olale, F., Gerzanich, V., Kuryatov, A., Wang, F., & Lindstrom, J. M. (1997) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37064-8 · Cited by 174 · see citing works
Olale, F., Gerzanich, V., Kuryatov, A., Wang, F., & Lindstrom, J. M. (1997) · PubMed · Cited by 172 · see citing works
Cognitive function during nicotine withdrawal: Implications for nicotine dependence treatment
Ashare, R. L., Falcone, M., & Lerman, C. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.04.034 · Cited by 170 · see citing works
File, S. E., Kenny, P. J., & Ouagazzal, A. (1998) · Behavioral Neuroscience · doi:10.1037/0735-7044.112.6.1423 · Cited by 166 · see citing works
McGranahan, T. M., Patzlaff, N. E., Grady, S. R., Heinemann, S. F., & Booker, T. K. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.0937-11.2011 · Cited by 165 · see citing works
Paperwalla, K. N., Levin, T. T., Weiner, J., & Saravay, S. M. (2004) · Medical Clinics of North America · doi:10.1016/j.mcna.2004.06.007 · Cited by 164 · see citing works
Potter, A., & NEWHOUSE, P. A. (2007) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2007.09.014 · Cited by 164 · see citing works
Nicotine, Brain Nicotinic Receptors, and Neuropsychiatric Disorders
Mihailescu, S., & Drucker-Colı́n, R. (2000) · Archives of Medical Research · doi:10.1016/s0188-4409(99)00087-9 · Cited by 162 · see citing works
TERCYAK, K. P., LERMAN, C., & AUDRAIN, J. (2002) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200207000-00011 · Cited by 162 · see citing works
Working memory in cigarette smokers: Comparison to non-smokers and effects of abstinence
Mendrek, A., Monterosso, J. R., Simon, S. L., Jarvik, M. E., Brody, A. L., Olmstead, R. E., Domier, C. P., Cohen, M. S., Monique Ernst, D., & London, E. D. (2005) · Addictive Behaviors · doi:10.1016/j.addbeh.2005.06.009 · Cited by 161 · see citing works
Hoyle, E., Genn, R. F., Fernandes, C., & Stolerman, I. P. (2006) · Psychopharmacology · doi:10.1007/s00213-006-0549-2 · Cited by 161 · see citing works
Smoking to self-medicate attentional and emotional dysfunctions
Gehricke, J., Loughlin, S. E., Whalen, C. K., Potkin, S. G., Fallon, J., Jamner, L. D., Belluzzi, J. D., & Leslie, F. M. (2007) · Nicotine & Tobacco Research · doi:10.1080/14622200701685039 · Cited by 159 · see citing works
Behavior and mutagenesis screens: The importance of baseline analysis of inbred strains
Tarantino, L. M., Gould, T. J., Druhan, J. P., & Bucan, M. (2000) · Mammalian Genome · doi:10.1007/s003350010107 · Cited by 158 · see citing works
Self-citationInhibition of Fear by Learned Safety Signals: minisymposium review
Christianson, J. P., Fernando, A., Kazama, A. M., Jovanović, T., Ostroff, L. E., & Sangha, S. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.3340-12.2012 · Cited by 158 · see citing works
Nicotine enhancement of contextual fear conditioning
Gould, T. J., & Wehner, J. M. (1999) · Behavioural Brain Research · doi:10.1016/s0166-4328(98)00157-0 · Cited by 151 · see citing works
Self-citationAbstinence effects as predictors of 28-day relapse in smokers
Swan, G. E., Ward, M. M., & Jack, L. M. (1996) · Addictive Behaviors · doi:10.1016/0306-4603(95)00070-4 · Cited by 150 · see citing works
Howe, W. M., Ji, J., Parikh, V., Williams, S., Mocaër, E., Trocmé-Thibierge, C., & Sarter, M. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2010.9 · Cited by 150 · cited 1× · see citing works
“In an operant sustained attention task, neither nicotine nor an α4β2 nAChR agonist, S38232, was effective but when a distractor cue was added, S38232 enhanced attention (Howe et al., 2010).”
BackgroundSelf-citationSalminen, O., Drapeau, J. A., McIntosh, J. M., Collins, A. C., Marks, M. J., & Grady, S. R. (2007) · Molecular Pharmacology · doi:10.1124/mol.106.031492 · Cited by 149 · see citing works
The Nicotinic Acetylcholine Receptor 5 Subunit Plays a Key Role in Attention Circuitry and Accuracy
Bailey, C. D. C., De Biasi, M., Fletcher, P. J., & Lambe, E. K. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.2258-10.2010 · Cited by 146 · see citing works
Withdrawal from Chronic Nicotine Administration Impairs Contextual Fear Conditioning in C57BL/6 Mice
Davis, J. A., James, J. R., Siegel, S. J., & Gould, T. J. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.2853-05.2005 · Cited by 146 · see citing works
Self-citationXiao, Y., Fan, H., Musachio, J. L., Wei, Z.-L., Chellappan, S. K., Kozikowski, A. P., & Kellar, K. J. (2006) · Molecular Pharmacology · doi:10.1124/mol.106.027318 · Cited by 141 · see citing works
Antidepressantlike effects of chronic nicotine on learned helplessness paradigm in rats
Semba, J., Mataki, C., Yamada, S., Nankai, M., & Toru, M. (1998) · Biological Psychiatry · doi:10.1016/s0006-3223(97)00477-0 · Cited by 140 · see citing works
Tronson, N. C., Schrick, C., Guzman, Y. F., Huh, K. H., Srivastava, D. P., Penzes, P., Guedea, A. L., Gao, C., & Radulovic, J. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.5619-08.2009 · Cited by 136 · see citing works
Hapke, U., Schumann, A., Rumpf, H.-J., John, U., Konerding, U., & Meyer, C. (2005) · The Journal of Nervous and Mental Disease · doi:10.1097/01.nmd.0000188964.83476.e0 · Cited by 133 · see citing works
Heavy Smokers, Smoking Cessation, and Clonidine
Green, J. (1988) · JAMA · doi:10.1001/jama.1988.03410110060016 · Cited by 133 · see citing works
Lasting synaptic changes underlie attention deficits caused by nicotine exposure during adolescence
Counotte, D. S., Goriounova, N. A., Li, K. W., Loos, M., van der Schors, R. C., Schetters, D., Schoffelmeer, A. N. M., Smit, A. B., Mansvelder, H. D., Pattij, T., et al. (2011) · Nature Neuroscience · doi:10.1038/nn.2770 · Cited by 132 · see citing works
Rabenstein, R. L., Caldarone, B. J., & Picciotto, M. R. (2006) · Psychopharmacology · doi:10.1007/s00213-006-0568-z · Cited by 129 · see citing works
Altered Anxiety-Related Responses in Mutant Mice Lacking the β4 Subunit of the Nicotinic Receptor
Salas, R., Pieri, F., Fung, B., Dani, J. A., & De Biasi, M. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-15-06255.2003 · Cited by 128 · see citing works
Howe, W. M., Berry, A. S., François, J., Gilmour, G., Carp, J., Tricklebank, M. D., Lustig, C., & Sarter, M. F. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.5809-12.2013 · Cited by 127 · see citing works
Zhu, J., Zhang, X., Xu, Y., Spencer, T. J., Biederman, J., & Bhide, P. G. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.1041-12.2012 · Cited by 125 · see citing works
Whiteaker, P., Davies, A. R. L., Marks, M. J., Blagbrough, I. S., Potter, B. V. L., Wolstenholme, A. J., Collins, A. C., & Wonnacott, S. (1999) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.1999.00685.x · Cited by 123 · see citing works
Nicotine enhances contextual fear conditioning in C57BL/6J mice at 1 and 7 days post-training
Gould, T. J., & Stephen Higgins, J. (2003) · Neurobiology of Learning and Memory · doi:10.1016/s1074-7427(03)00057-1 · Cited by 123 · see citing works
Self-citationCaldarone, B. J., Harrist, A., Cleary, M. A., Beech, R. D., King, S. L., & Picciotto, M. R. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.08.010 · Cited by 122 · see citing works
Ouagazzal, A.-M., Kenny, P. J., & File, S. E. (1999) · Psychopharmacology · doi:10.1007/s002130050976 · Cited by 121 · see citing works
Fuemmeler, B. F., Kollins, S. H., & McClernon, F. J. (2007) · Journal of Pediatric Psychology · doi:10.1093/jpepsy/jsm051 · Cited by 121 · see citing works
Neural Systems Involved in Fear Inhibition: Extinction and Conditioned Inhibition
Davis, M., Falls, W., & Gewirtz, J. C. (2000) · Neurobiological foundation of aberrant behaviors · doi:10.1007/978-1-4757-4860-4_8 · Cited by 115 · see citing works
Beane, M., & Marrocco, R. T. (2004) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2004.09.001 · Cited by 114 · see citing works
Animal models of depression: navigating through the clinical fog
Matthews, K., Christmas, D. M., Swan, J., & Sorrell, E. (2005) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2005.03.005 · Cited by 112 · see citing works
Gatto, G. J., Bohme, G. A., Caldwell, W. S., Letchworth, S. R., Traina, V. M., Obinu, M. C., Laville, M., Reibaud, M., Pradier, L., Dunbar, G., et al. (2004) · CNS Drug Reviews · doi:10.1111/j.1527-3458.2004.tb00010.x · Cited by 111 · see citing works
Cigarette Smoking, Anxiety, and Depression
Morrell, H. E. R., & Cohen, L. M. (2006) · Journal of Psychopathology and Behavioral Assessment · doi:10.1007/s10862-005-9011-8 · Cited by 109 · see citing works
Davis, J. A., Kenney, J. W., & Gould, T. J. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.3242-07.2007 · Cited by 107 · see citing works
Self-citationBriscione, M. A., Jovanovic, T., & Norrholm, S. D. (2014) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2014.00088 · Cited by 105 · see citing works
Wehner, J. M., Keller, J. J., Keller, A. B., Picciotto, M. R., Paylor, R. E., Booker, T. K., Beaudet, A. L., Heinemann, S., & Balogh, S. A. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2004.07.016 · Cited by 105 · see citing works
Semenova, S., Stolerman, I. P., & Markou, A. (2007) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2007.05.009 · Cited by 104 · see citing works
Cigarette smoking associated with attention deficit hyperactivity disorder
Wilens, T. E., Vitulano, M., Upadhyaya, H., Adamson, J., Sawtelle, R., Utzinger, L., & Biederman, J. (2008) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2008.04.030 · Cited by 103 · see citing works
Slotkin, T. A., Seidler, F. J., Qiao, D., Aldridge, J. E., Tate, C. A., Cousins, M. M., Proskocil, B. J., Sekhon, H. S., Clark, J. A., Lupo, S. L., et al. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300544 · Cited by 101 · see citing works
Molecular Diversity of Neuronal Nicotinic Acetylcholine Receptors
McGehee, D. S. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb11330.x · Cited by 101 · see citing works
Prenatal smoking exposure and psychiatric symptoms in adolescence
Indredavik, M. S., Brubakk, A., Romundstad, P., & Vik, T. (2007) · Acta Paediatrica · doi:10.1111/j.1651-2227.2006.00148.x · Cited by 101 · see citing works
Andreasen, J., Olsen, G., Wiborg, O., & Redrobe, J. (2009) · Journal of Psychopharmacology · doi:10.1177/0269881108091587 · Cited by 101 · see citing works
Schneider, T., Ilott, N., Brolese, G., Bizarro, L., Asherson, P. J. E., & Stolerman, I. P. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2010.249 · Cited by 97 · see citing works
Contemporary Issues in Modeling Psychopathology
Myslobodsky, M. S. (2000) · Neurobiological foundation of aberrant behaviors · doi:10.1007/978-1-4757-4860-4 · Cited by 92 · see citing works
(S)‐3‐メチル‐5‐(1‐メチル‐2‐ピロリジニル)イソキサゾール(ART418) 認知促進および抗不安活性を持つ新しいコリン作動性リガンド II in vivoの性質
Decker, M. W., Brioni, J. D., Sullivan, J. P., et al. (1994) · Journal of Pharmacology and Experimental Therapeutics · Cited by 92 · see citing works
Yochum, C. L., Doherty-Lyons, S., Hoffman, C. A., Hossain, M. M., Zelikoff, J. T., & Richardson, J. R. (2014) · Experimental Neurology · doi:10.1016/j.expneurol.2014.01.016 · Cited by 90 · see citing works
Transgenerational Transmission of Hyperactivity in a Mouse Model of ADHD
Zhu, J., Lee, K. P., Spencer, T. J., Biederman, J., & Bhide, P. G. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.4402-13.2014 · Cited by 90 · see citing works
Irvine, E. E., Cheeta, S., & File, S. E. (1999) · Behavioural Pharmacology · doi:10.1097/00008877-199911000-00016 · Cited by 89 · cited 3× · see citing works
“Specifically, Irvine et al. (1999) found that nicotine injections 5 min before the behavioral test decreased social interaction, an anxiogenic effect, while injections 30 min before the task increased social interaction, an anxiolytic effect.”
BackgroundMethodResultTurner, J. R., Castellano, L. M., & Blendy, J. A. (2010) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.110.166280 · Cited by 88 · cited 2× · see citing works
“The discrepancy between Rollema et al. (2009) and Turner et al. (2010) results is likely to be due to the different mouse strains used by these two studies, C57BL/6J mice and 129SvJ-C57BL/6J F1 hybrid mice, respectively.”
BackgroundResultTolerance to nicotine's effects in the elevated plus-maze and increased anxiety during withdrawal
Irvine, E. E., Cheeta, S., & File, S. E. (2001) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(00)00449-4 · Cited by 88 · see citing works
Vázquez-Palacios, G., Bonilla‐Jaime, H., & Velázquez‐Moctezuma, J. (2004) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2004.08.008 · Cited by 87 · see citing works
Rollema, H., Guanowsky, V., Mineur, Y. S., Shrikhande, A., Coe, J. W., Seymour, P. A., & Picciotto, M. R. (2009) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2009.01.002 · Cited by 87 · see citing works
Deficits in a sustained attention task following nicotine withdrawal in rats
Shoaib, M., & Bizarro, L. (2005) · Psychopharmacology · doi:10.1007/s00213-004-2004-6 · Cited by 87 · see citing works
Schleicher, H. E., Harris, K. J., Catley, D., & Nazir, N. (2009) · Journal of American College Health · doi:10.3200/jach.57.5.507-512 · Cited by 84 · see citing works
Barbaresi, W. J., Katusic, S. K., Colligan, R. C., Weaver, A. L., Pankratz, V. S., Mrazek, D. A., & Jacobsen, S. J. (2004) · Acta Paediatrica · doi:10.1111/j.1651-2227.2004.tb03058.x · Cited by 82 · see citing works
Andreasen, J. T., & Redrobe, J. P. (2009) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e32832c713e · Cited by 82 · see citing works
Tobacco use among middle and high school students --- United States, 2000-2009.
(2010) · PubMed · Cited by 81 · see citing works
Treatment Strategies for Patients With Psychiatric Comorbidity
Backus, V. P. (1998) · Psychiatric Services · doi:10.1176/ps.49.4.542 · Cited by 79 · see citing works
Davis, J. A., & Gould, T. J. (2005) · Psychopharmacology · doi:10.1007/s00213-005-0047-y · Cited by 78 · see citing works
Self-citationNicotine enhances trace cued fear conditioning but not delay cued fear conditioning in C57BL/6 mice
Gould, T. J., Feiro, O., & Moore, D. (2004) · Behavioural Brain Research · doi:10.1016/j.bbr.2004.04.009 · Cited by 78 · see citing works
Self-citationNicotine-induced Attentional Enhancement in Rats Effects of Chronic Exposure to Nicotine
Hahn, B. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(02)00348-2 · Cited by 78 · see citing works
Rukstalis, M., Jepson, C., Patterson, F., & Lerman, C. (2005) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2005.02.002 · Cited by 78 · see citing works
Anxiolytic-like effects of the novel cholinergic channel activator ABT-418
Brioni, J. D., O'Neill, A. B., Kim, D. J., Buckley, M. J., Decker, M. W., & Arneric, S. P. (1994) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)22796-3 · Cited by 77 · cited 2× · see citing works
“For example, an α4β2 nAChR agonist, ABT-418, was found to increase open arm time in the EPM and both ABT-418 and an α4β2 nAChR partial agonist, ABT-089, reversed the anxiogenic effects of nicotine withdrawal (Brioni et al., 1994; Decker et al., 1994; Yohn, Turner, & Blendy, 2014).”
BackgroundProgesterone modulation of α5 nAChR subunits influences anxiety‐related behavior during estrus cycle
Gangitano, D., Salas, R., Teng, Y., Perez, E., & De Biasi, M. (2009) · Genes, Brain and Behavior · doi:10.1111/j.1601-183x.2009.00476.x · Cited by 76 · see citing works
Davis, J. A., & Gould, T. J. (2007) · Psychopharmacology · doi:10.1007/s00213-006-0624-8 · Cited by 72 · see citing works
Self-citationBeckham, J. C., Feldman, M. E., Vrana, S. R., Mozley, S. L., Erkanli, A., Clancy, C. P., & Rose, J. E. (2005) · Experimental and Clinical Psychopharmacology · doi:10.1037/1064-1297.13.3.219 · Cited by 70 · see citing works
Mood, major depression, and fluoxetine response in cigarette smokers
(1995) · American Journal of Psychiatry · doi:10.1176/ajp.152.3.398 · Cited by 70 · see citing works
Young, J. W., Meves, J. M., & Geyer, M. A. (2013) · Behavioural Brain Research · doi:10.1016/j.bbr.2012.11.028 · Cited by 69 · see citing works
Lotfipour, S., Byun, J. S., Leach, P., Fowler, C. D., Murphy, N. P., Kenny, P. J., Gould, T. J., & Boulter, J. (2013) · The Journal of Neuroscience · doi:10.1523/jneurosci.4731-12.2013 · Cited by 68 · see citing works
Self-citationCellular, molecular, and genetic substrates underlying the impact of nicotine on learning
Gould, T. J., & Leach, P. T. (2013) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2013.08.004 · Cited by 68 · see citing works
Self-citationCigarette smoking and depressive symptoms: A longitudinal study of adolescents and young adults
Brook, J. S., Schuster, E., & Zhang, C. (2004) · Psychological Reports · doi:10.2466/pr0.95.1.159-166 · Cited by 68 · see citing works
Smoking During Adolescence as a Risk Factor for Attention Problems
Treur, J. L., Willemsen, G., Bartels, M., Geels, L. M., van Beek, J. H. D. A., Huppertz, C., van Beijsterveldt, C. E. M., Boomsma, D. I., & Vink, J. M. (2015) · Biological Psychiatry · doi:10.1016/j.biopsych.2014.06.019 · Cited by 67 · see citing works
Effects of chronic low- and high-dose nicotine on cognitive flexibility in C57BL/6J mice
Ortega, L. A., Tracy, B. A., Gould, T., & Parikh, V. (2012) · Behavioural Brain Research · doi:10.1016/j.bbr.2012.10.032 · Cited by 67 · see citing works
Self-citationThe prevalence of psychiatric comorbidity.
Kessler, R. C. (1997) · Cited by 67 · see citing works
Portugal, G. S., Kenney, J. W., & Gould, T. J. (2008) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2007.05.002 · Cited by 66 · see citing works
Self-citationNicotine dependence, PTSD symptoms, and depression proneness among male and female smokers
Thorndike, F. P., Wernicke, R. A., Pearlman, M. Y., & Haaga, D. A. F. (2005) · Addictive Behaviors · doi:10.1016/j.addbeh.2005.04.023 · Cited by 66 · see citing works
Choline transporter gene variation is associated with attention-deficit hyperactivity disorder
English, B. A., Hahn, M. K., Gizer, I., Mazei-Robison, M., Steele, A., Kurnik, D., Stein, M., Waldman, I., & Blakely, R. (2009) · Journal of Neurodevelopmental Disorders · doi:10.1007/s11689-009-9033-8 · Cited by 65 · see citing works
Nicotine enhances both foreground and background contextual fear conditioning
Davis, J. A., Porter, J., & Gould, T. J. (2006) · Neuroscience Letters · doi:10.1016/j.neulet.2005.10.026 · Cited by 65 · see citing works
Self-citationKenney, J. W., Raybuck, J. D., & Gould, T. J. (2012) · Hippocampus · doi:10.1002/hipo.22003 · Cited by 65 · see citing works
Self-citationMirza, N., & Bright, J. (2001) · Psychopharmacology · doi:10.1007/s002130000605 · Cited by 65 · see citing works
Nicotine improves performance in an attentional set shifting task in rats.
Allison, C., & Shoaib, M. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.06.055 · Cited by 63 · see citing works
Predictors of lapse in first week of smoking abstinence in PTSD and non-PTSD smokers
Beckham, J. C., Calhoun, P. S., Dennis, M. F., Wilson, S. M., & Dedert, E. A. (2013) · Nicotine & Tobacco Research · doi:10.1093/ntr/nts252 · Cited by 61 · see citing works
Hippocampal nAChRs mediate nicotine withdrawal-related learning deficits
Davis, J. A., & Gould, T. J. (2009) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2009.02.003 · Cited by 60 · see citing works
Self-citationGoodwin, R. D., Lewinsohn, P. M., & Seeley, J. R. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.04.042 · Cited by 59 · see citing works
Portugal, G. S., Wilkinson, D. S., Kenney, J. W., Sullivan, C., & Gould, T. J. (2012) · Behavior Genetics · doi:10.1007/s10519-011-9489-7 · Cited by 58 · see citing works
Self-citationGould, T. J., Portugal, G. S., André, J. M., Tadman, M. P., Marks, M. J., Kenney, J. W., Yildirim, E., & Adoff, M. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.01.003 · Cited by 56 · cited 3× · see citing works
“…hippocampal nAChRs desensitize and upregulate and the resulting hypersensitive cholinergic system may be responsible for the effects of nicotine withdrawal on hippocampus-dependent learning (Dani & Heinemann, 1996; Gould et al., 2012; Marks, Grady, & Collins, 1993; Wilkinson & Gould, 2013).”
BackgroundSelf-citationThakur, G. A., Sengupta, S. M., Grizenko, N., Schmitz, N., Pagé, V., & Joober, R. (2012) · Nicotine & Tobacco Research · doi:10.1093/ntr/nts102 · Cited by 56 · see citing works
Stimulant treatment of ADHD and cigarette smoking: a meta-analysis
Schoenfelder, E. N., Faraone, S. V., & Kollins, S. H. (2014) · Pediatrics · doi:10.1542/peds.2014-0179 · Cited by 55 · see citing works
Raybuck, J. D., & Gould, T. J. (2009) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2008.06580.x · Cited by 53 · see citing works
Self-citationParikh, V., Peters, M. S., Blakely, R., & Sarter, M. F. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.4993-12.2013 · Cited by 53 · see citing works
Self-citationMcClernon, F. J., Voorhees, E. E. V., English, J. S., Hallyburton, M., Holdaway, A., & Kollins, S. H. (2011) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntr073 · Cited by 51 · see citing works
Rezvani, A. H., Cauley, M., Sexton, H., Xiao, Y., Brown, M. L., Paige, M. A., McDowell, B. E., Kellar, K. J., & Levin, E. D. (2011) · Psychopharmacology · doi:10.1007/s00213-010-2161-8 · Cited by 50 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Kutlu, M. G., & Gould, T. J. (2016) · Learning & Memory · doi:10.1101/lm.042192.116 · Cited by 324 · see citing works
Self-citationEngland, L. J., Aagaard, K., Bloch, M., Conway, K., Cosgrove, K., Grana, R., Gould, T. J., Hatsukami, D., Jensen, F., Kandel, D., et al. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.11.013 · Cited by 181 · see citing works
Self-citationGenome-wide association study implicates CHRNA2 in cannabis use disorder
Demontis, D., Rajagopal, V. M., Thorgeirsson, T. E., Als, T. D., Grove, J., Leppälä, K., Gudbjartsson, D. F., Pallesen, J., Hjorthøj, C. R., Reginsson, G. W., et al. (2019) · Nature Neuroscience · doi:10.1038/s41593-019-0416-1 · Cited by 133 · see citing works
Anxiety and Nicotine Dependence: Emerging Role of the Habenulo-Interpeduncular Axis
Molas, S., DeGroot, S. R., Zhao-Shea, R., & Tapper, A. R. (2016) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2016.11.001 · Cited by 100 · see citing works
Parikh, V., Kutlu, M. G., & Gould, T. J. (2016) · Schizophrenia Research · doi:10.1016/j.schres.2016.01.020 · Cited by 95 · see citing works
Self-citationBesson, M., & Forget, B. (2016) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2016.00160 · Cited by 73 · see citing works
Depression and substance use disorders: Clinical comorbidity and shared neurobiology
Calarco, C. A., & Lobo, M. K. (2020) · International review of neurobiology · doi:10.1016/bs.irn.2020.09.004 · Cited by 69 · see citing works
Okoli, C. T. C., Seng, S., Otachi, J. K., Higgins, J. T., Lawrence, J. N., Lykins, A., & Bryant, E. (2019) · International Journal of Mental Health Nursing · doi:10.1111/inm.12682 · Cited by 61 · see citing works
Impacts of Nicotine and Flavoring on the Sensory Perception of E-Cigarette Aerosol
Pullicin, A. J., Kim, H., Brinkman, M. C., Buehler, S., Clark, P. I., & Lim, J. (2019) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntz058 · Cited by 53 · see citing works
Mukherjee, J., Lao, P. J., Betthauser, T. J., Samra, G. K., Pan, M., Patel, I. H., Liang, C., Metherate, R., & Christian, B. T. (2017) · The Journal of Comparative Neurology · doi:10.1002/cne.24320 · Cited by 43 · see citing works
Understanding Inequalities of Maternal Smoking—Bridging the Gap with Adapted Intervention Strategies
Boucher, J., & Konkle, A. T. M. (2016) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph13030282 · Cited by 41 · see citing works
Goldberg, L. R., Zeid, D., Kutlu, M. G., Cole, R. D., Lallai, V., Sebastian, A., Albert, I. U., Fowler, C. D., Parikh, V., & Gould, T. J. (2019) · Addiction Biology · doi:10.1111/adb.12859 · Cited by 38 · see citing works
Self-citationZhang, M., Zhang, D., Dai, J., Cao, Y., Xu, W., He, G., Wang, Z., Wang, L., Li, R., & Qiao, Z. (2020) · Toxicology · doi:10.1016/j.tox.2020.152367 · Cited by 33 · see citing works
Calarco, C. A., Fox, M. E., Terheyden, S. V., Turner, M. D., Alipio, J. B., Chandra, R., & Lobo, M. K. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.737389 · Cited by 26 · see citing works
Nicotine consumption during the prodromal phase of schizophrenia – a review of the literature
Γώγος, Α., Σκώκου, Μ., Ferentinou, E., & Gourzis, P. (2019) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s210199 · Cited by 25 · see citing works
Chemosensory Contributions of E-Cigarette Additives on Nicotine Use
Johnson, N. L., Patten, T., Ma, M., Biasi, M. D., & Wesson, D. W. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.893587 · Cited by 19 · see citing works
GENOME-WIDE ASSOCIATION STUDY IMPLICATES CHRNA2 IN CANNABIS USE DISORDER
Demontis, D., Rajagopal, V. M., Als, T. D., Grove, J., Pallesen, J., Hjorthøj, C., Qvist, P., Christensen, J., Bybjerg‐Grauholm, J., Bækvad‐Hansen, M., et al. (2019) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2018.07.008 · Cited by 18 · see citing works
Calarco, C. A., Lee, S., & Picciotto, M. R. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.06.012 · Cited by 17 · see citing works
Chronic nicotine increases alcohol self-administration in adult male Wistar rats
Montanari, C., Secci, M. E., Driskell, A., McDonald, K. O., Schratz, C. L., & Gilpin, N. W. (2020) · Psychopharmacology · doi:10.1007/s00213-020-05669-8 · Cited by 17 · see citing works
Bruijnzeel, A. W. (2016) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntw303 · Cited by 14 · see citing works
Psychological Features of Smokers
Gülşen, A., & Uygur, B. (2018) · Respiratory Care · doi:10.4187/respcare.06287 · Cited by 13 · see citing works
Exploring the association between melatonin and nicotine dependence (Review)
GEORGAKOPOULOU, V. E., Sklapani, P., Τράκας, Ν., Reiter, R. J., & Spandidos, D. A. (2024) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2024.5406 · Cited by 12 · see citing works
Health Risks Associated with Tobacco Consumption in Humans: An Overview
Sakthisankaran, S. M., Sakthipriya, D., & Swamivelmanickam, M. (2024) · Journal of Drug Delivery and Therapeutics · doi:10.22270/jddt.v14i5.6523 · Cited by 10 · see citing works
Li, H., Zhao, J., Liang, J., & Song, X. (2023) · PLoS ONE · doi:10.1371/journal.pone.0287027 · Cited by 10 · see citing works
Syan, S. K., Belisario, K. L., Rahman, L., Levitt, E. E., McCarron, C. E., Radman, H., Amlung, M. T., Praecht, A., George, T. P., & MacKillop, J. M. (2025) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntaf089 · Cited by 9 · see citing works
Zvorsky, I. A., Skelly, J. M., & Higgins, S. T. (2017) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntx111 · Cited by 9 · see citing works
Ning, H., Huang, B., Tae, H., Liu, Z., Yu, S., Li, L., Zhang, L., Adams, D. J., Guo, C., & Dai, Q. (2021) · Journal of Neurochemistry · doi:10.1111/jnc.15434 · Cited by 8 · see citing works
Deng, L., Wang, Q., & Lou, Y. (2023) · Brain and Behavior · doi:10.1002/brb3.3052 · Cited by 8 · see citing works
Conway, K. P., Michel, E., Eig, S., He, J.-P., & Merikangas, K. R. (2025) · American Journal of Psychiatry · doi:10.1176/appi.ajp.20230988 · Cited by 8 · see citing works
Özsoy, E., Griffiths, M. D., Karaçay, G. T., Onay, Ö. A., Yılmaz, C., & Balaban, Ö. (2025) · Australian Journal of Psychology · doi:10.1080/00049530.2025.2486774 · Cited by 7 · see citing works
Vlasceanu, A.-M., Grădinaru, D., Stan, M., Nitescu, V. G., & Baconi, D. L. (2023) · Antioxidants · doi:10.3390/antiox12061299 · Cited by 6 · see citing works
Tobacco consumption and quality of life among teachers: a bidirectional problem
Lizana, P. A., Vilches‐Gómez, V., Lisseth Barra, C., & Lera, L. (2024) · Frontiers in Public Health · doi:10.3389/fpubh.2024.1369208 · Cited by 6 · see citing works
Psychological features of adult patients with langerhans cell histiocytosis
Bugnet, E., Gupta, N., Lorillon, G., Arbabzadeh‐Bouchez, S., Lemogne, C., Chevret, S., & Tazi, A. (2021) · PLoS ONE · doi:10.1371/journal.pone.0246604 · Cited by 5 · see citing works
Correlates of Tobacco Use Among People with Mental Illness Within Asia: A Scoping Review
Parul, P., Joseph, B., Datta, S., & Rahman, M. A. (2024) · Community Mental Health Journal · doi:10.1007/s10597-024-01336-w · Cited by 4 · see citing works
Seng, S., Otachi, J. K., & Okoli, C. T. C. (2019) · Issues in Mental Health Nursing · doi:10.1080/01612840.2019.1630533 · Cited by 4 · see citing works
Baldassarri, S. R., Asch, R., Hillmer, A. T., Pietrzak, R. H., DellaGioia, N., Esterlis, I., & Davis, M. T. (2023) · Chronic Stress · doi:10.1177/24705470231154842 · Cited by 4 · see citing works
Shafiee, A., Goodarzi, M., Firouzabadi, S. R., Mohammadi, I., Sadeghi, D., Zarei, M., Abdollahi, A., Kolahdooz, A., & Bakhtiyari, M. (2024) · Depression and Anxiety · doi:10.1155/2024/8530368 · Cited by 3 · see citing works
Indoor tanning bed use and risk of food addiction based on the modified Yale Food Addiction Scale
Li, W., John, E., Cho, E., Alan, F., Shaowei, W., Ascherio, A., Rimm, E. B., Alison, F., & Abrar, A. (2017) · Journal of Biomedical Research · doi:10.7555/jbr.31.20160098 · Cited by 3 · see citing works
Vaping Regulations and Mental Health of High School StudentsPreprint
Choudhury, R. S. (2021) · SSRN Electronic Journal · doi:10.2139/ssrn.3773745 · Cited by 3 · see citing works
E-Cigarette Taxation and Queer Youth
Chuo, A., Cotti, C. D., Courtemanche, C., Maclean, J. C., Nesson, E. T., & Sabia, J. J. (2025) · National Bureau of Economic Research · doi:10.3386/w33326 · Cited by 3 · see citing works
Neurobiology and Mechanisms of Nicotine Addiction
Gogineni, H. P., Sachs, D. P. L., & Brunzell, D. H. (2023) · Respiratory medicine · doi:10.1007/978-3-031-24914-3_3 · Cited by 2 · see citing works
Venkatesh, S. K., Stangl, B. L., Yan, J., Cardé, N. A. Q., Stein, E. A., Diazgranados, N., Schwandt, M. L., Sun, H., Momenan, R., Goldman, D. A., et al. (2024) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyae035 · Cited by 2 · see citing works
The Intersection of Sexual Orientation, Substance Use, and Mental Health: Findings from Hints 5
Bouraleh, S. M., & Bishwajit, G. (2024) · Healthcare · doi:10.3390/healthcare12202083 · Cited by 1 · see citing works
Sang, E., Silva, S. G., Grenon, S., Swinkels, C., Shakya, S., Deshmukh, S., Fish, L. J., Costa, M. D., Simmons, L. A., Severson, H. H., et al. (2025) · Frontiers in Public Health · doi:10.3389/fpubh.2025.1565910 · Cited by 1 · see citing works
Nicotine Dependence and Its Impact on Poly-Tobacco Use Among US Adults
Zhao, X., Li, W., & Osibogun, O. I. (2025) · Substance Use & Misuse · doi:10.1080/10826084.2025.2544302 · Cited by 1 · see citing works
(2025) · Frontiers research topics · doi:10.3389/978-2-8325-7071-5 · Cited by 1 · see citing works
The effects of e-cigarette and cigarette policies on queer youth
Chuo, T., Cotti, C. D., Courtemanche, C., Maclean, J. C., Nesson, E. T., & Sabia, J. J. (2026) · Journal of Health Economics · doi:10.1016/j.jhealeco.2026.103116 · Cited by 1 · see citing works
Alameer, M. B., Emam, O. A., Yakoub‐Agha, L., Alkadi, S., Azzawi, M. E. A. S. A., Haidar, N., Habeeb, R., & Jawich, K. (2026) · Health Science Reports · doi:10.1002/hsr2.72035 · Cited by 1 · see citing works
Andersson, J., Berglund, K. J., Irmel, R., & Adermark, L. (2026) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntag148 · Cited by 2 · see citing works
Kutlu, M. G., Holliday, E. L., & Gould, T. J. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802574-1.00004-1
Self-citationSmoking and diabetes: An unhealthy relationship
Phillips, A. (2018) · Practice Nursing · doi:10.12968/pnur.2018.29.3.110
Palmisano, A. N. (2019) · OpenCommons at University of Connecticut (University of Connecticut)
SMALL MEDICAL CYCLOTRON PRODUCED RADIOISOTOPES: FROM CLASSIC TO NOVEL RADIOTRACERS
Ciucă, A., Măirean, C. P., Spac, A., Dimofte, G., & Hăncianu, M. (2019) · The Medical-Surgical Journal
Substance Use Disorders and Psychiatric Multimorbidity
Justo, L. P. (2021) · Springer eBooks · doi:10.1007/978-3-030-62855-0_14
Smoking as a method of coping for medical workers
", Grati, L., & Creanga", I. (2021) · The Moldovan Medical Journal · doi:10.52418/moldovan-med-j.64-3.21.03
Andry, T., Shorter, D. I., & Kosten, T. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-809324-5.00290-x
Lane, S. D., Shahani, L., Machado‐Vieira, R., & Soares, J. C. (2024) · Psychiatry Research Communications · doi:10.1016/j.psycom.2024.100167
Chen, Y. (2025) · Journal of Studies on Alcohol and Drugs · doi:10.15288/jsad.24-00455
Chiappini, S., Sampogna, G., Ventriglio, A., Menculini, G., Ricci, V., Pettorruso, M., Volpe, U., & Martinotti, G. (2025) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2025.2506463
Hanewinkel, R., & Hansen, J. (2026) · Substance Use & Misuse · doi:10.1080/10826084.2026.2617436
Exploring the Relationship Between Smoking and Brain Functional Connectivity in Schizophrenia
Kahn, R. (2026) · Oxford Journal of Student Scholarship · doi:10.65161/rechkqv6sf7frpixm
Jiao, B., Yu, Y., Li, W., Wan, J., Zhang, Y., Deng, S., Zhang, J., Qi, X., Chen, S., & Lv, H. (2026) · Chinese Chemical Letters · doi:10.1016/j.cclet.2026.112681
Oral Nicotine Pouches: An Emerging Central Nervous System Toxicant
López-Ojeda, W., & Hurley, R. A. (2026) · Journal of Neuropsychiatry · doi:10.1176/appi.neuropsych.20250291
Andersson, J., Hansson, M., Ericson, M., & Adermark, L. (2026) · Tobacco Use Insights · doi:10.1177/1179173x261455075
E-cigarette use among adults in southern Iran: a qualitative study
Rastegar, Y., Kakhaki, H. E. S., Abolghaseminejad, P., Dadipoor, S., Yari, A., & Kalan, M. E. (2026) · BMC Public Health · doi:10.1186/s12889-026-27917-w
Nicotine in Neurodegenerative and Neuropsychiatric Disorders: Mechanisms and Clinical Evidence
Bjørklund, G., Gurgas, L., & Hangan, T. (2026) · Neurochemical Research · doi:10.1007/s11064-026-04845-0
Adamou, M., & Petrou, C. (2026) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2026.1966206
- Authors
- Kutlu, M. G., Parikh, V., & Gould, T. J.
- Affiliations
- Temple University (US)
- Corresponding author
- Gould, Thomas J.
- Venue
- International Review of Neurobiology
- Publisher
- Elsevier
- Published
- 2015
- Volume
- 124
- Pages
- 171-208
- ISSN
- 0074-7742 (ISSN-L)
- PMC
- PMC5755398
- OpenAlex
- W2417002138
- Semantic Scholar
- b757f3a90ef2d1bb4bd56d31fec894fe26504325
- Cited by
- 65
- References
- 241
- Citations by year
- 2026: 10 · 2025: 8 · 2024: 8 · 2023: 5 · 2022: 1 · 2021: 6 · 2020: 3 · 2019: 9 · 2018: 2 · 2017: 4 · 2016: 9
- FWCI
- 16.50
- Type
- book chapter
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- International review of neurobiology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute on Drug Abuse (DA017949, R01DA017949)
- Topics
- Health Sciences › Medicine › Physiology › Smoking Behavior and Cessation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nicotinic Acetylcholine Receptors Study
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Prenatal Substance Exposure Effects
- Keywords
- nicotine dependence, psychiatric comorbidity, attention deficit hyperactivity disorder, anxiety disorders, depression, self-medication, nicotinic acetylcholine receptors, nAChR subunits, receptor desensitization, receptor up-regulation
- MeSH terms
- Mental Disorders, Humans, Nicotine, Receptors, Nicotinic, Tobacco Use Disorder
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-10.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-10.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review